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ABSTRACT 
WISEWOMAN (WW) is a comprehensive program for medically underserved women in 
South Dakota (SD), aged 30 to 64, which aims to reduce morbidity and mortality from 
chronic diseases. Screening services include blood total cholesterol, blood pressure and 
blood glucose, and body mass index (BMI). Lifestyle intervention (LSI) sessions are also 
offered to address physical activity and nutrition. The purpose of this retrospective 
longitudinal study was to quantitatively examine whether the combination of LSI’s and 
clinical screenings or clinical screenings alone lead to improvements in blood pressure, 
blood glucose, total cholesterol, and/or BMI at rescreening 10 to14 months from initial 
screening. Guided by the social ecological model ,it was hypothesized that SD-WW  
participants attending the screening sessions as well as the intervention sessions would 
have greater reductions in blood pressure, total cholesterol, and blood glucose than 
participants who only received screenings. Participants included 653 low-income women 
aged 30 to 64 enrolled in the screening alone (N=423) and SD-WW program (N=230) 
from 2000-2005, who completed both the screening and rescreening 10 to14 months 
later. Secondary data analysis using forced-entry multiple regression of the traditional 
measures employed in the screening alone control condition yielded significant predictive 
models for change scores in blood pressure, BMI, blood glucose, and cholesterol among 
all participants. Neither dummy variable regression nor ANOVA results indicated any 
significant impact of the SD-WW intervention on these same health outcome changes.  
Findings contribute to positive social change by demonstrating that screening alone is 
effective in predicting health outcomes, thus allowing more disadvantaged women to be 
served by public agencies that may face reduced funding for their array of programs. 
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CHAPTER 1  
INTRODUCTION TO THE STUDY 
Introduction  
Heart disease is the leading cause of death for South Dakota women, accounting 
for 24.7% (n = 865) of all deaths in this group during 2006. Congestive heart failure in 
South Dakota mirrors the national rate. The age-adjusted rate of congestive heart failure 
in South Dakota women was 131.5 out of 100,000 (SD Vital Statistics Report, 2006), 
while the age-adjusted rate among women in the United States was 131.2 out of 100,000 
(Centers for Disease Control [CDC], 2006). Among deaths from congestive heart failure 
in the state since 2002, 60% were women (SD Vital Statistics Report, 2006).  
Among all female adults 18 and older in South Dakota, 3.2% reported having 
experienced myocardial infarction (a heart attack) in 2006 (CDC, 2006). Education level 
was a significant predictor of heart attack risk factor among South Dakota women: 8.4% 
of women with eighth grade or less education report having a heart attack compared with 
1.8% of women with a college degree. Approximately 3% of South Dakota women have 
angina or coronary heart disease (CDC, 2006). Heart disease prevalence decreases as 
education level increases. Women with a college education were less likely to report 
diagnosis of coronary heart disease than women with an 8th grade or less education (2.1% 
vs. 7.8%; CDC, 2006). South Dakota’s crude rate of coronary heart disease among 
women, is higher (179.7 / 100,000) than the United States average (163.7 / 100,000). 
Trends in several major risk factors for cardiovascular disease are discouraging. 
In 2006, 19.1% of female respondents to South Dakota’s Behavioral Risk Factors 
Surveillance System (CDC, 2006) survey stated they were current cigarette smokers. 
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Cigarette smoking is three times more common among American Indian women than 
White women (50.4% vs. 16.3%). Of South Dakota WISEWOMAN enrollees, 37% 
smoke; this is the highest incidence of smoking reported by any of the 15 currently 
funded WISEWOMAN projects. The percentage of the female population that is 
overweight and obese has increased dramatically over the past decade. In 2006, 54.7% of 
female South Dakotans were overweight or obese (Behavioral Risk Factor Surveillance 
System [BRFSS], 2006). Obesity is most prevalent among American Indian women: 
77.1% are overweight or obese. Nationally, 61.8% of women are overweight or obese. 
About one quarter (24%) of all BRFSS respondents do not participate in any leisure-time 
physical activity. This risk factor is also more prevalent among American Indians 
females, of whom 38% report participating in no leisure-time physical activity, that is 
respondents that report no leisure time physical activity or exercise during the past 30 
days other than the respondent’s regular job. Nationally, 22% of all BRFSS respondents 
participate in no leisure-time physical activity.  
In 2005, only 25% of women in South Dakota reported consuming at least the 
recommended five servings of fruits and vegetables per day (BRFSS, 2005). Nationwide, 
the rate is somewhat lower at 23.2%, a small but statistically significant difference (CDC, 
2006). In 2005, 25% of women in South Dakota reported high blood pressure (SD 
BRFSS, 2005). Prevalence of hypertension among American Indian and White females is 
relatively similar (25.8% vs. 25%). Approximately one third (32.6%) of female BRFSS 
respondents indicated having been diagnosed with high blood cholesterol levels. There 
was no significant difference between American Indian women and White women 
(32.4% vs. 30.3%) in this risk factor.  
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According to the CDC (2006), 6.5% of South Dakota female BRFSS 
respondents reported having been diagnosed with diabetes. Diabetes is almost three times 
as prevalent among American Indian females as among White females (16.7% vs. 6%). 
Nationally, diabetes affects 7.5% of all women (CDC, 2006). Prevalence of diabetes 
decreases as education level increases. Women with a college education are one fourth 
more likely to report diagnosis with diabetes than women with an 8th grade or less 
education (3.9% vs. 13.8%; CDC, 2006).  
Cardiovascular disease and risk factors leading to cardiovascular disease 
disproportionately affect American Indian women in South Dakota. Health disparities 
among American Indian populations in South Dakota are complex phenomena that are 
longstanding and require long-term commitment and comprehensive approaches.  
Background 
The Well-Integrated Screening and Evaluation for Women Across the Nation 
(WISEWOMAN) is a comprehensive program for medically underserved women to 
reduce morbidity and mortality from chronic diseases. WISEWOMAN is an extension of 
the National Breast and Cervical Cancer Early Detection Programs (NBCCEDP) funded 
by the CDC. Screening services include blood cholesterol, blood pressure, and blood 
sugar. Nutrition and physical activity interventions are delivered through three individual, 
one-on-one sessions with the interventionist, that are based on A New Leaf-Choices for 
Healthy Living (University of North Carolina, 2001) and Active Living Every Day (Blair, 
Dunn, Marcus, Carpenter, & Jaret, 2001). The New Leaf curriculum is based on the 
transtheoretical model of behavioral change. The Active Living workbook was developed 
by the Cooper Aerobics Center in Dallas, TX, based upon a successfully tested cognitive-
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behavioral approach to improving physical activity.  
Theoretical Foundation 
The WISEWOMAN project was founded on the transtheoretical model of 
behavior change (Diclemente & Proschaska, 1983) and the health belief model (HBM) 
(Simons-Morton, Greene, & Gottlieb, 1995). The transtheoretical model of behavior 
change describes the five stages of behavior change in which individuals can enter and 
exit stages at any given time. The five stages of change include precontemplation, 
contemplation, preparation, action, and maintenance (Diclemente & Proschaska, 1983). 
According to Simons-Morton et al., the HBM is a value-driven theory in that it attempts 
to explain and predict health behaviors by focusing on the individuals desire to prevent 
illness or rehabilitate from an illness. The core elements addressed by the HBM include 
perceived threat, perceived sustainability, perceived severity, perceived benefits, 
perceived barriers, cues to action, and self-efficacy.  
The theoretical foundation for which this research project is based upon is the 
socioecological model, which explains how individual behavior can be influenced at 
multiple levels: individual, interpersonal, organizational, community, and public policy 
(Institute of Medicine, 2003). The model combines individual behavior with social and 
physical environments, while recognizing the level of self-responsibility that individuals 
have to take for positive lifestyle change and the outside forces that influence individual 
behavior. The socioecological model acknowledges the interwoven relationship between 
the individual and their environment. The socioecological model explains how lifestyle 
choices are individual choices made in the midst of the various environments in which 
the individual is nested (Institute of Medicine, 2003). The WISEWOMAN program 
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targets the individual and interpersonal levels by focusing on what motivates the 
woman, while the interpersonal level is addressed in that the WISEWOMAN program 
provides social support for the woman. Addressing these levels is an essential program 
component, as they provide the fundamental support necessary for behavior change to 
occur.  
On September 30, 2000, the South Dakota Department of Health received funds 
from the CDC’s WISEWOMAN program to integrate cardiovascular disease (CVD) and 
diabetes screening services into the Department’s existing National Breast and Cervical 
Cancer Early Detection Program (BCCEDP). The addition of the WISEWOMAN 
program in South Dakota reduces morbidity and mortality resulting from chronic disease 
among the medically underserved population. South Dakota’s BCCEDP program serves 
women 30 to 64 years old. In order to create a system that is both patient and provider-
friendly, the AWC! WISEWOMAN program also serves women aged 30 to 64. The 
population of low-income women in South Dakota aged 30 to 64 is 39,823 (South Dakota 
Department of Social Services, 2006). 
The greatest need for WISEWOMAN services in the state is among low-income 
women. Table one indicates the percentage of women without insurance by race. About 
one in every ten South Dakota women (9.9%) is uninsured (N = 16,696).  
Table 1 
South Dakota Women Without Health Insurance by Race (CDC, 2006) 
 
Race / Ethnicity % of women without health insurance 
American Indian 1.10% 
Hispanic 15.80% 
White 10.20% 
Total 9.90% 
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Statement of the Problem 
Adoption and maintenance of health behavior change is a public health challenge, 
particularly from those populations suffering from health disparities. While the quality of 
life and chronic disease risk reduction benefits of healthy eating and regular physical 
activity are well understood, the ability to promote adherence to a lifetime of these health 
behaviors is limited (Institute of Medicine, 2001). The major problem is that while 
intervention strategies that lead to adoption of healthy behaviors are well developed, 
knowledge of how to facilitate sustained health behavior is not readily available in the 
current body of research. 
Cardiovascular disease and risk factors leading to cardiovascular disease 
disproportionately affect women in South Dakota’s disparate populations. More research 
is needed related to cardiovascular disease and its risk factors among low-income women 
in South Dakota WISEWOMAN if health disparities are to be reduced.. 
Purpose of the Study  
The purpose of this retrospective longitudinal study was to quantitatively examine 
whether the combination of Lifestyle Intervention Sessions (LSI)sessions and clinical 
screenings or clinical screenings alone lead to improvements in blood pressure, blood 
glucose, total cholesterol, and/or body mass index (BMI) as measured at rescreening 10 
to14 months from initial screening. This study provides information to the SD 
WISEWOMEN program regarding the effectiveness of LSI support for clinical screening 
as opposed to clinical screening to improve health. The results effect future program 
implementation decisions and serve as a model of WISEWOMAN program evaluation 
for the CDC. 
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Research Questions and Hypotheses 
The primary research questions that are addressed in this dissertation include:  
1. Is the change in blood glucose level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screening 
only? 
2. Is the change in BMI, as measured at rescreening 10 to14 months from initial 
screening, different for women enrolled in the South Dakota WISEWOMAN program 
lifestyle intervention than women receiving clinical screenings only? 
3. Is the change in total cholesterol level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screenings 
only?  
4. Is the change in blood pressure level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screenings 
only? 
 The primary research hypotheses addressed in this dissertation are: 
1. Women attending at least one Lifestyle Intervention Session will experience a 
larger reduction in blood glucose than women receiving only clinical screening as 
measured at rescreening 10 to14 months from initial screening.  
2. Women attending at least one Lifestyle Intervention Session will experience a 
larger reduction in BMI than women receiving only clinical screening as measured at 
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rescreening 10 to14 months from initial screening.  
3. Women attending at least one Lifestyle Intervention Session will experience a 
larger reduction in total cholesterol levels than women receiving only clinical screening 
as measured at rescreening 10 to14 months from initial screening.  
4. Women attending at least one Lifestyle Intervention Session will experience a 
larger reduction in their blood pressure levels than women receiving only clinical 
screening as measured at rescreening 10 to14 months from initial screening.  
Definition of Terms 
Participation in the South Dakota WISEWOMAN program: was defined 
conceptually as either participation in the intervention sessions or participation in the 
screening and rescreen at 10 to14 months. An operational definition for participation in 
the South Dakota WISEWOMAN: according to the South Dakota WISEWOMAN 
program (2008) is the enrollment of an uninsured/underinsured woman aged 30 to 64 in 
the NBCCEDP program and All Women Count! (AWC!) chronic disease screening 
program by the medical provider, at initial screening session. The dependent variables in 
this dissertation study were BMI, total cholesterol, blood pressure, and blood glucose. In 
order to measure each variable, an index of unique identifiers such as dates, interventions, 
and rescreen results were made and then aggregate data was analyzed to determine if 
change occurred.  
High blood pressure: is defined as having systolic blood pressure equal to or 
greater than 140 mmHg or diastolic blood pressure equal to or greater than 90 mmHg, or 
taking medication for high blood pressure.  
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High cholesterol: is defined as having total cholesterol equal to or greater than 
240 mg/dl or taking medication for high cholesterol (CDC WISEWOMAN, 2005). 
Overweight: is defined as having BMI of 25 to 29.9, while obese is defined as 
having a BMI equal to or greater than 30. BMI is calculated using CDC standards: BMI = 
(weight in pounds) divided by (ht in inches squared) times (703). Prediabetes is defined 
as a fasting blood glucose of 100 to125mg/dl or a nonfasting glucose of 140 to 199 mg/dl 
(CDC WISEWOMAN, 2005).  
Diabetes: is defined as a fasting blood glucose equal to or greater than 126mg/dl 
or a nonfasting glucose equal to or greater than 200 mg/dl or history of diabetes or taking 
medication for diabetes (CDC WISEWOMAN, 2005).  
Significance 
The study findings will impact social change by elucidating whether health 
outcomes among women who receive LSI sessions and screenings differ from women 
who only receive the clinical screening and rescreening in improving blood pressure, 
blood glucose, total cholesterol, and/or BMI. Understanding whether the more intensive 
intervention (screening sessions along with LSI) has greater influence on biological 
outcomes than the less intensive method (screening alone) will assist in the design of 
more effective public programs aimed at improving the health in population groups 
similar to those served in South Dakota. Since South Dakota’s WISEWOMAN program 
includes a substantial number of at-risk women, the results of this study will be of value 
to other states that have similar proportions of this disparate population.  
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Assumptions 
There is an absence of medication histories for each participant in this study. The 
South Dakota Department of Health or MaxTrac chose not to include medications in the 
MDE (minimal data elements) that it collects because all participants in need of 
medications were referred to the Department of Social Services RX Access program. 
Medications would influence the variable if they are at all efficacious. There is no reason 
to believe, however, that medication use varied between women in the LSI groups and 
women who received clinical screening only. It was also assumed that all participants 
were South Dakota female residents that met the age and income requirements for 
program enrollment. However, to assess this assumption age was examined in the data 
analysis. It was also essential to assume that the lab results and measurements of blood 
pressure, blood glucose, BMI, and total cholesterol were accurate. However, it is 
recognized that there can be bias in self-reported health behaviors.  
Limitations 
Methodological issues in the sample for this research limited the external validity 
of this study. Since clients were not randomly assigned to groups, unmeasured variables 
confound the results. Another limitation of the study was the absence of medication 
histories for each participant. The South Dakota Department of Health or MaxTrac chose 
not to include medications in the MDE (minimal data elements) that it collects because 
all participants in need of medications were referred to the Department of Social Services 
RX Access program. American Indian data are lacking in this dissertation study because 
of a simple billing issue. Indian Health Service (IHS) does not submit bills to the South 
Dakota WISEWOMAN program for screening. If the program does not pay the bill, then 
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the woman can not be enrolled in the WISEWOMAN program. This would appear to 
be a straightforward problem to fix; however, it has been ongoing since the program 
began. 
Summary 
Cardiovascular disease is the leading cause of death among women in South 
Dakota. While cardiovascular disease is preventable, the adoption and maintenance of 
healthy behavior change is not well understood. More research is needed to quantitatively 
examine whether women enrolled in the lifestyle intervention sessions experience a 
greater reduction in blood pressure, blood glucose, total cholesterol, and/or BMI as 
compared to those women receiving only clinical screening, as measured at rescreening 
10 to14 months from the initial screening.   
Current research conclusions and recommendations within the literature are 
reviewed and summarized in chapter 2. An exhaustive review of the literature yielded 
significant data to provide a theoretical framework and validate the outcomes presented 
in this dissertation. Research methodology and protection of human subjects will be 
detailed in chapter 3. The results are presented in chapter 4. Lastly, the recommendations 
and implications for social change are addressed in chapter 5. 
  
CHAPTER 2: 
LITERATURE REVIEW 
Introduction 
This chapter reviews and summarizes lifestyle interventions research studies. It 
also reviews the researcher’s theoretical framework, empirical WISEWOMAN studies, 
WISEWOMAN lifestyle interventions and the WISEWOMAN best-practices.  
The Well-Integrated Screening and Evaluation for Women Across the Nation 
(WISEWOMAN) is an extension of the National Breast and Cervical Cancer Early 
Detection Programs (NBCCEDP) funded by the CDC. Screening services include blood 
cholesterol, blood pressure and blood sugar. The LSI sessions offer women with elevated 
or alert screening values (CDC WISEWOMAN, 2005) up to four lifestyle interventions. 
The elevated value for blood pressure was classified as >140/90 but <180/110 mm Hg, 
while an alert value was >180/110 mm Hg. The elevated value for total cholesterol was 
>= 200 mg/dl, while the alert value was >= 400mg/dl. The elevated value for blood 
glucose (Fasting Plasma Glucose Test) was >= 126mg/dl, while the alert value was >= 
200 mg/dl. A BMI between 25 and 29.99 was classified as overweight, while a BMI of 
30 or above was classified as obese.  
 The 39 AWC! interventionists meet with women in person, by phone, or through 
self-study (by correspondence). The program is also developing web-based intervention 
support services using popular new internet media and communication technologies to 
reach out to its widely-distributed target population (South Dakota WISEWOMAN, 
2008). Participating women complete rescreening between 10 and 14 months after 
baseline screening. AWC! has provided WISEWOMAN services to one third of South 
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Dakota’s BCCEDP-eligible women.  
The remainder of this chapter reviews the theoretical framework that guides both 
this study and the WISEWOMAN program. Evaluation studies published describing 
WISEWOMAN projects are reviewed, and the limitations of those studies, and the 
unanswered questions that will be addressed in this study.    
Theoretical Framework  
The theoretical framework on which the South Dakota WISEWOMAN 
interventions are based includes the transtheoretical model of behavior change 
(Diclemente & Proschaska, 1983) and the health belief model (Simons-Morton et al., 
1995). The theoretical foundation for which this research project is based upon is the 
socioecological model (Institute of Medicine, 2003). The transtheoretical model may be a 
key to impacting individual choices regarding lifestyle and health-related behaviors. The 
transtheoretical model was developed in the late 1970s and early 1980s by Prochaska and 
DiClemente at the University of Rhode Island. The transtheoretical model of behavior 
change describes the five stages of behavior change in which individuals can enter and 
exit stages at any given time. The five stages of change include precontemplation, 
contemplation, preparation, action, and maintenance (Diclemente & Proschaska, 1983). 
Using the transtheoretical model as a guide to individual behavior change, intervention 
strategies can be formulated that will assist and motivate individuals to change their 
lifestyles and make healthier choices. Lifestyle interventions are most effective when 
they match the individuals’ readiness to change (Will & Loo, 2008). In the specific 
program explored in this dissertation, women receive counseling messages that facilitate 
their ability to advance from not thinking about healthy eating or physical activity 
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(precontemplation stage) or thinking about healthy eating or physical activity 
(contemplation stage) to taking small steps toward changing these health behaviors 
(preparation stage). The ultimate goal is regularly eating a heart healthy diet and 
participating in physical activity most days of the week (action stage). The assessment 
form used by the WISEWOMAN program assists program staff in determining 
interventions for each participant. 
The health belief model (HBM) attempted to explain and predict health behaviors 
by focusing on the individuals desire to prevent illness or rehabilitate from an illness 
(Simons-Morton et al., 1995). The HBM theorized why people fail to initiate and sustain 
positive change (Janz & Becker, 1984). The core elements addressed by the HBM 
include perceived threat, perceived sustainability, perceived severity, perceived benefits, 
perceived barriers, cues to action, and self-efficacy. Jointly, the core elements aim to 
predict whether a woman will adhere to a healthy lifestyle to decrease her overall risk for 
chronic disease.  
Perceived threat refers to the belief that one is at risk for a specific health threat, 
while perceived susceptibility addresses that individual’s risk perception. Perception 
varies greatly among people. A person’s perceived benefits are influential in the adoption 
and continuance of the overall behavior change (Janz & Becker, 1984). Individual beliefs 
regarding the overall impact of a particular change differ. The perceived barriers to a 
positive behavior change/action can impede initiation and/or adherence to a particular 
program (Janz & Becker, 1984). Cues to action are events that initiate action. Self-
efficacy is the belief that one can follow-through with the action (Strecher & Rosenstock, 
1997).  
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The theoretical foundation for which this research project is based upon is the 
socioecological model. According to the socioecological model, individual behavior can 
be influenced at multiple levels: individual, interpersonal, organizational, community, 
and public policy (Institute of Medicine, 2003). The model combines individual behavior 
with social and physical environments, while recognizing the level of self-responsibility 
that individuals have to take for positive lifestyle change and the outside forces that 
influence individual behavior. The socioecological model acknowledges the interwoven 
relationship between the individual and their environment. Behavior is influenced largely 
by individual, intrapersonal, organizational, community, and public policy. Barriers to 
healthy behaviors are common within the community as a whole; however, as barriers are 
addressed or removed, behavior change among the women is achievable and sustainable. 
The physical and social environments in which people live play a large role in 
influencing individual behavior.  
The socioecological model focuses upon the larger universe of influences on 
human behavior. It offers strategies for potential behavior changes at various levels. This 
model explains how lifestyle choices are individual choices made in the midst of the 
various environments in which the individual is nested (Institute of Medicine, 2003). The 
WISEWOMAN program targets the individual and intrapersonal levels by focusing on 
what motivates the woman, while the interpersonal level is addressed in that the 
WISEWOMAN program provides social support for the woman. Addressing these levels 
is an essential program component, as they provide the fundamental support necessary 
for behavior change to occur. Figure one illustrates the logic model for the 
WISEWOMAN program.  
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Figure 1. South Dakota WISEWOMAN logic model (South Dakota Department of 
Health, 2008). 
An outcome evaluation is defined by the CDC (1999) as a “systematic collection 
of information to assess the impact of a program, present conclusions about the merit or 
worth of a program, and make recommendations about future program direction or 
development” (p. 2). Evaluation information is an essential part of evidence-based  
decision-making and the evaluator is most effective by focusing the evaluation based 
upon the needs of managers, policymakers, administrators, and practitioners (Fitzpatrick, 
Sanders, & Worthen, 2004). The framework for the South Dakota WISEWOMAN 
outcome evaluation will compare the change in blood pressure, blood glucose, total 
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cholesterol, and BMI between women attending screening sessions and lifestyle 
intervention sessions and women attending only clinical screening and rescreening at 10 
to14 months. This evaluation will assist project leaders by providing data to help improve 
the efficacy, reach, and cost-effectiveness of WISEWOMAN.  
WISEWOMAN Study Procedures 
The process used to screen participants for heart disease and stroke risk factors 
through South Dakota’s WISEWOMAN program mirrors the national procedures. It is 
comprised of four steps. First, participants complete the program enrollment form. 
Completion of the form enrolls participants in both the BCCEDP and WISEWOMAN 
components of AWC! The form includes a brief description of the programs, a consent 
for release of information, personal data (e.g., name, demographic information, screening 
history, and medical treatment history), and eligibility determination questions (to be 
completed by the provider staff member verifying the woman’s eligibility for BCCEDP). 
When a participant’s eligibility for the program has been verified by a provider-site staff 
member, the participant moves into the office visit phase of the screening process. This 
phase includes blood pressure measurements, blood draws and weight and height 
measurements.  
Next, the participant completes the AWC! assessment form. This form requests 
information about the participant’s personal health history. Information requested 
includes previous diagnoses of high cholesterol, high blood pressure, or diabetes; 
smoking history; history of medically-recommended inactivity; exercise and stretching 
habits; fruit and vegetable consumption; and weight history. The form also asks 
participants to indicate which learning style suits them best (in-person counseling, 
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telephone counseling, or self-study). Program staff uses this information to plan 
interventions for each participant. 
Participants move into the office visit phase of the screening process where blood 
pressure measurements, blood draws, and weight and height measurements are taken. Lab 
Summary Forms and Visit Summary Forms are the standard reporting forms for the 
Program. The Lab Summary Form is used to report blood lipids; blood glucose, 
quantitative or Glycated Hemoglobin (HbA1c). In some cases diagnostic tests may be 
needed such as; Calcium, Comprehensive Metabolic panel, Creatinine, Microalbumin, 
Potassium, Urinalysis, Oral Glucose Tolerance Test. The laboratory or screening clinic 
sends the Lab Summary Form directly to the Department of Health, AWC! Program. 
After the participant leaves the provider-site, provider staff complete lab work on the 
blood draws, complete the enrollment form by adding screening result values, and 
submits the form to the WISEWOMAN central office at the South Dakota Department of 
Health Laboratory.  
South Dakota’s AWC! WISEWOMAN program is unique in that all 267 
screening provider sites are capable, qualified, and equipped to provide all necessary 
diagnostic services. After screening is complete, providers submit participants’ 
enrollment forms (including screening values) to the AWC! central office. The Records 
Manager ensures that data from each form are entered into the project data system 
provided by external contractor MaxTrac. MaxTrac generates a referral notice for the 
assigned interventionist. The system emails a notice to the interventionist, who can then 
log into the secure data system from any web-connected computer and reviews all 
information about the participant (including screening values).Within one week, the 
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interventionist sends the participant a welcome letter and brochure about the 
intervention (South Dakota WISEWOMAN, 2008). 
Between a week and 10 days later, the interventionist attempts to contact the 
participant by phone. The interventionist tries to contact the participant at least three 
times over a period of 2 weeks before closing the referral. When the interventionist 
contacts the participant by phone, they make arrangements for second and third 
intervention sessions in person, by phone, or through self-study. The LSI sessions offer 
women with elevated or alert screening values up to four lifestyle interventions in person, 
by phone, or through self-study.  
South Dakota’s lifestyle interventions are based on DiClemente and Prochaska’s 
(1983) stages of change model. The interventionists differentiate and personalize 
intervention services offered to participating women based on the individual factors 
including risk factors, behavioral goals and willingness to change. Each factor is 
described in more detail below. 
Risk Level 
 The AWC! program staff divide women into three categories based on their level 
of risk. Low risk women are those that have screening values (BMI, blood pressure, and 
all labs) within normal ranges for all indicators. Moderate risk women have at least one 
screening value in the elevated range. High risk women have at least one value in the 
alert range (South Dakota WISEWOMAN, 2008). Based upon risk level the woman 
receives either minimal or enhanced intervention sessions (South Dakota 
WISEWOMAN, 2008). The minimal intervention involves screening, referral and on-site 
counseling (South Dakota WISEWOMAN, 2008). The enhanced intervention sessions 
  
 
20
include screening, referral, and extended on-site counseling, plus skill building and 
facilitation of programs to improve diet and physical activity (South Dakota 
WISEWOMAN, 2008). 
Behavioral Goals 
 Interventionists assess women’s conceptual understanding of behavioral goals 
during verbal risk reduction counseling and intervention sessions. Interventionists also 
assist women who have never or only infrequently set behavioral goals related to healthy 
behaviors learn how to choose goals that are reasonable and well-defined. Women who 
already understand how to set clear and attainable health goals for themselves are assisted 
with deciding what their short- and mid-range goals should be (South Dakota 
WISEWOMAN, 2008). 
Willingness to Change 
AWC! assesses women’s readiness to change in two ways. During the first 
intervention session, participants are asked to indicate their level of interest in taking part 
in free nutrition and physical activity education. The participant’s response to this 
question gives the interventionists a preliminary indicator of her readiness to accept the 
idea that her health condition might call for lifestyle changes. Interventionists are trained 
to measure women’s readiness to change during their initial telephone call using a 
motivational interviewing algorithm (South Dakota WISEWOMAN, 2008).  
Based on participants’ initial motivational interview, interventionists indicate 
which stage best describes each participant. Information about a woman’s risk-level, 
behavioral goals, and readiness to change determines the intensity and emphasis of the 
woman’s intervention program and the strategies used to work through her objections and 
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concerns about lifestyle changes. For example, women at the contemplation stage are 
encouraged to examine the pros and cons of adopting healthy lifestyle habits whereas 
interventionists help women at the action stage develop self-efficacy for dealing with 
obstacles. 
The South Dakota Department of Health uses the evidence-informed, culturally 
appropriate curriculum called A New Leaf: Choices for Healthy Living (New Leaf). This 
curriculum forms the core of every woman’s AWC! lifestyle intervention program, 
regardless of the format in which she chooses to participate in intervention sessions. New 
Leaf comprises sections on ten topics: (a) food assessment and tips, (b) healthy eating, (c) 
physical activity assessment and tips, (d) keeping active, (e) weight assessment and tips, 
(f) a healthy weight, (g) diabetes prevention and management, (h) bone health assessment 
and tips, (i) smoking and quitting assessment and tips, and (j) stress and depression. The 
manual’s authors wrote to a sixth-grade reading level so as not to overwhelm participants 
with limited literacy. Colorful graphics are used to organize the manual and call attention 
to summary material. Participants can choose to participate in interventions in person, 
over the phone, or via self-study. Participating women complete rescreening between 10 
and 14 months after baseline screening.  
Participants in South Dakota’s AWC! WISEWOMAN program also have access 
to resources that support healthy lifestyles and behaviors through a statewide network of 
community coalitions. Each coalition receives funding from a statewide Federal Physical 
Activity and Nutrition grant from the CDC, to bring together healthy living resources in 
their communities. Most of the 267 AWC! provider sites are close to at least one healthy 
living coalition (South Dakota WISEWOMAN, 2008). The AWC! interventionists refer 
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participants they are assigned to serve to their local coalition for help accessing local 
resources (South Dakota WISEWOMAN, 2008). In addition, the Department of Health’s 
Office of Community Health Services maintains an office in 63 of South Dakota’s 66 
counties (South Dakota WISEWOMAN, 2008). Each office maintains a registry of 
community healthy lifestyle resources in their county that WISEWOMAN participants 
can access (South Dakota WISEWOMAN, 2008). For example, the Department of Health 
(2007) forged a partnership with the South Dakota Department of Game, Fish, and Parks 
and all WISEWOMAN participants receive a pass enabling them to access every South 
Dakota state park free of charge. The Department of Health offers a wide array of healthy 
lifestyle resources to program participants online and over the telephone free of charge.  
Review of Empirical Studies 
A literature review, beginning with publications in 2001, was conducted using the 
following search engines: EBSCO, ProQuest, Ingenta, Medline Plus, PubMed, and 
Highwire Press. Using the keyword WISEWOMAN alone and in combination with 
intervention, lifestyle intervention, behavioral intervention, chronic disease screening, 
cardiovascular disease, South Dakota, and woman/women. Other terms, including blood 
pressure and cholesterol screening, in combination with women and the United States 
also were used.  
Low-income populations are at-risk for chronic disease (Liao et al., 2004). 
Healthy behaviors are influenced by environment (Haber & Looney, 2003). Although 
intervention programs targeting low-income, lower socioeconomic neighborhoods and 
environments are  rare, there are some community-based intervention programs targeted 
at disparate populations. Jilcott, Laraia, Evenson, Lowenstein, and Ammerman (2007) 
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synthesized WISEWOMAN research projects and current community-based 
intervention tools into one document. Both qualitative and quantitative research was 
included. A pilot study with women residing in the community was also conducted to 
assess the overall effectiveness of the materials provided in the intervention. The 
researchers concluded that barriers to healthy behaviors included access to fast food, 
crime, high cost of fitness centers, lack of child care, and lack of information about 
physical activity. Jillcott and her colleagues suggested that the WISEWOMAN program 
is capable of tailoring the intervention to address women’s unique barriers to healthy 
behaviors within the community served.  
Will et al. (2004) identified barriers to intervention sessions such as provider 
skepticism, social isolation, unsafe neighborhoods, and access to healthy foods. The 
WISEWOMAN program is currently revamping the structure of the intervention sessions 
and adopting the socioecological model into intervention planning.   
Functioning of WISEWOMAN Programs 
The WISEWOMAN program is being implemented in three phases. Phase one 
(1995-1998) focused on research, in phase two (1999-2007) funding was divided into two 
categories: research funding or standard projects funding. Implementation of phase three 
has just begun for fiscal year 2009. Will and Loo (2008) summarized the lessons learned 
and the challenges to be addressed in phase three. In phase one, the WISEWOMAN 
conducted randomized controlled trials, nonrandomized control trials, and quasi-
experimental (pre/posttest), cross-sectional studies, case studies, as well as conducted 
interviews to obtain qualitative data. Using those collected data, phase two set 
performance indicators for the nonresearch WISEWOMAN sites. In phase three, Will 
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and Loo identified key challenges and recommendations. Some of the challenges 
identified were maximizing program reach in order to tailor the program resources to 
participants’ needs, targeting at-risk/disparate populations using vital statistics and 
hospital discharge data, and providing theory driven behavioral counseling and 
interventions, increasing rescreening rates, and increasing community partnerships and 
collaborations. The program recommendations were focused primarily on clarifying and 
defining the vision of the WISEWOMAN program and increasing program reach and 
effectiveness. By addressing these challenges, it is hoped that the WISEWOMAN will be 
able to serve more women and provide more screenings, which will in-turn, reduce 
cardiovascular disease in the target population.   
Sanders et al. (2001) conducted a needs assessment to identify training needs of 
WISEWOMAN project staff in relation to nutrition counseling and education 
development and implementation. WISEWOMAN staff received training that addressed 
the gaps identified in the needs assessment. At the 6-month follow-up, a majority of the 
participants indicated that the course increased their knowledge and skills in program 
planning. Using the evaluation of the course, the CDC WISEWOMAN team intends to 
further assess program training on topics addressed in the behavior counseling and 
education.  
Mays et al. (2004) conducted a formative assessment of perceived opportunities, 
challenges, and strategies associated with integrating WISEWOMAN into community 
health center settings. In 2002, a panel of 21 stakeholders provided qualitative input to 
assist in the improvement of the WISEWOMAN capacity to reduce the burden of 
cardiovascular disease among WISEWOMAN participants. They found that the 
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stakeholders have issues with the integration of the WISEWOMAN program in 
community health centers. Barriers such as competing demands on health center 
resources, difficulties hiring new staff for new programs, and administrative burdens 
associated with data collection and reporting were identified.  
The Community Change Chronicles was drafted by staff at the North Carolina 
Department of Health and Human Services (2009) to highlight policy change and the 
promotion of cardiovascular health. Lewis, Johnson, Farris, and Will (2004) set forth to 
explore the methods used in North Carolina’s WISEWOMAN program and conducted an 
exhaustive review of literature to evaluate program strengths and weaknesses and 
promote research-based interventions. Their conclusions are summarized below.  
The North Carolina WISEWOMAN program assessed the project staff attitudes, 
beliefs, and barriers to successful implementation of the program. Jilcott et al. (2004) 
conducted a cross-sectional baseline and one year follow-up of program staff to find out 
more information in regards to their beliefs about WISEWOMAN participants’ 
motivation, diet, and physical activity behaviors. The results indicated that staff felt that a 
majority of the WISEWOMAN participants were not motivated to change their current 
lifestyle in regards to dietary change and physical activity. The staff felt that they had 
adequate resources to assist in behavior change. The staff also felt that time, access to 
low-cost medication, lack of attendance at follow-up sessions, and program 
implementation in clinic sites were challenges in sustaining the WISEWOMAN program.  
In order to assess the maintenance of health behavior, 22 North Carolina 
WISEWOMAN sites, consisting of 511 participants, were randomly assigned to a 
computer-based post 12 month health messaging intervention or control group. Data were 
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obtained using telephone administered surveys, which introduces bias into the study 
because of self-report. Jacobs et al. (2004) found that the enhanced intervention 
participants were more likely to adhere to a healthy diet than the control group.  
A quantitative and qualitative evaluation of the Iowa WISEWOMAN program 
was conducted by Gatewood and colleagues in 2008 to identify barriers to physical 
activity and nutrition. Participant’s self-efficacy in relation to program participation was 
also examined in order to identify variables predictive of program participation. The 
random sample consisted of 339 WISEWOMAN participants in Iowa between March 
2003 and January 2006. The sample was representative of women who attended six or 
more interventions; women attending only one intervention session; and women who did 
not attend any intervention sessions. A paper survey assessed barriers to intervention 
attendance, barriers to health behavior change, food security, and self-efficacy for 
nutrition and physical activity. The results of the survey indicated that women that did 
not attend intervention sessions or women who attended only one session were more 
likely to report perceived barriers to intervention attendance than those who attended at 
least six intervention sessions. Although this study had a small sample size, the results are 
helpful for health promotion planning. The authors concluded that interventions needed 
to fit better into the women’s lives. The time, place, location were not sensitive to the 
program participants lifestyle. The intervention content also needs to address the 
participant’s perceived risk (Gatewood et al., 2008). 
Viadro, Farris, and Will (2004) conducted a review of case studies from three 
WISEWOMAN sites (Arizona, North Carolina, and Massachusetts) to assess phase one 
project design and implementation. Data were obtained from document review and 
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telephone interviews with project directors, coordinators, researchers, and a CDC 
project officer. Using those data, Viadro et al. identified themes across the project sites. 
The themes identified that a strong, research-based intervention and screening evaluation 
needed to be implemented, research and program services needed to be combined, and 
NBCCEDP and WISEWOMAN needed to be better integrated. All three project sites 
were deemed successful in serving at-risk women and strengthening partnerships to 
develop a comprehensive women’s health model and develop linkages in the community 
to better serve and support the needs of the WISEWOMAN participants.  
Review of the Lifestyle Interventions  
The WISEWOMAN program provides chronic disease screenings and lifestyle 
interventions for disparate women aged 40 to 64 in the United States. In South Dakota, 
women aged 30 to 64 are eligible because of the small population base in the state (South 
Dakota WISEWOMAN, 2008). In the initial phase of the program, North Carolina, 
Massachusetts, and Arizona were awarded funding to conduct enhanced projects (CDC 
WISEWOMAN, 2003). These sites had both intervention and control groups (CDC 
WISEWOMAN, 2003). In phase two of the WISEWOMAN program, funding was 
awarded for standard projects (CDC WISEWOMAN, 2003).The standard projects did not 
have control groups (CDC WISEWOMAN, 2003). The aim of the standard projects was 
to assess the cost/benefit of the program. In 2004, Will, Farris, Sanders, Stockmyer, and 
Finkelstein conducted a study to assess the overall feasibility and effectiveness of the 12 
WISEWOMAN project sites. Data were collected for 8164 participants in 2002. The 
outcome measures used were blood pressure, lipid levels, and tobacco use. Intermediate 
measures include self-reported diet and physical activity, measures of readiness for 
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change, and barriers to behavior change. The screening provided by the program 
resulted in 24% of women being newly diagnosed as having high blood pressure (24%) 
and high cholesterol (48%). Among the participants, 75% were obese, while 42% 
reported themselves as current smokers. Screening sessions clearly had an impact; 
however, the overall effectiveness of the intervention sessions was not as clear. This 
study illustrated that the WISEWOMAN program is reaching the target audience that are 
at risk for chronic disease.  
WISEWOMAN participants have high BMI and there is a high prevalence of 
smoking among participants (Mobley, Finkelstein, Khavjou, & Will, 2004). The 
WISEWOMAN program offers lifestyle intervention sessions to improve participants’ 
overall health and help the women quit smoking. Between January 2001 and December 
2002, Mobley et al. conducted an analysis of WISEWOMAN participants from 
Connecticut, Michigan, Nebraska, North Carolina, and South Dakota to examine BMI 
and smoking behavior in conjunction to neighborhood socioeconomic characteristics. 
Using zip codes, the authors concluded that there is a link between economically 
disadvantaged neighborhood and rates of smoking and obesity (p< 0.05). Although this 
study revealed spatial clustering in regards to cardiovascular risk factors, it is not 
inclusive of all WISEWOMAN sites, nor did the authors indicate the total number of 
participants in this particular study. There was also potential bias in that smoking rates 
were self-reported. This study provided the WISEWOMAN program with useful 
information to address chronic disease risk factor disparities in economically challenged 
communities across South Dakota.   
WISEWOMAN participants with abnormal or alert lab values are able to obtain 
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medication to control blood pressure, cholesterol, and diabetes at free and reduced 
cost. In 2007, Khavjou, Finkelstein, and Will studied the impact of the medication access 
on coronary heart disease risk factors among 2385 WISEWOMAN participants in eight 
states. A pre-post analysis was used to estimate risk factor changes by medication status 
at 12 months. The participants who received medication had significant improvements in 
overall blood pressure and total cholesterol levels. The authors concluded that there was a 
reduction in coronary heart disease risk factors using the screening and lifestyle 
intervention sessions.  
Will, Khavjou, Finkelstein, Loo, and Gregory-Mercado (2007) conducted a study 
to quantify the overall benefit of medicinal use on glucose, cholesterol, and ten year 
coronary heart disease risk among 29,387 WISEWOMAN participants from 1998 to 
2005. Ten year coronary heart disease risk estimates a 10-year probability of developing 
a coronary heart disease. It is assessed using a formula developed by Anderson (1991) 
that uses sex, age, systolic blood pressure, total cholesterol, high-density lipoprotein 
cholesterol, smoking, and diabetes status as input risk factors to help explain the change 
in 10-year CHD risk. Will et al. (2007) used baseline and follow-up data for prediabetic 
(n= 688) or diabetic (n= 338) participants, the researchers employed a multilevel 
regression model. They found that that 2.9% of prediabetic participants experienced 
statistically significant improvements in their glucose, 2.1% improvement in cholesterol 
level, and 4.3% improvement in ten year coronary heart disease risk; 11.5% of newly 
diagnosed diabetics had statistically significant improvements in their glucose level, 3.1% 
to 3.5% had improvement in their blood pressure, and 6.4% of their total cholesterol 
levels improved. Among those with previously diagnosed diabetes, 1.9% to 3.4% had 
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significant improvement in their blood pressure, 3.8% had improvement in total 
cholesterol, and 8.5% had improvement in ten year coronary heart disease risk (p < .05). 
The researchers concluded that comprehensive, patient driven interventions will 
effectively produce the same results as presented in the WISEWOMAN program, if 
replicated on a much broader scale.  
The WISEWOMAN program addresses racial/ethnic disparities in cardiovascular 
disease. Finkelstein, Khavjou, Mobley, Haney, and Will (2004) assessed BMI, blood 
pressure, total cholesterol, diabetes, and smoking prevalence in relation to their 10 year 
cardiovascular disease risk. High total cholesterol, hypertension, and diabetes awareness 
and access to treatment were also examined. Baseline and rescreen data were collected, 
representing 5596 WISEWOMAN participants from January 2001 to December 2002. 
Using regression analysis, the results indicated a racial/ethnic disparity among the 
WISEWOMAN participants. African Americans were the most at-risk population with 
more obesity, higher blood pressure and diabetes rates, and a higher 10 year coronary 
heart disease risk (p < 0.05).   
In 2008 Feresu, Zhang, Puumala, Ullrich, and Anderson examined the Nebraska 
WISEWOMAN program to assess cardiovascular risk factors and changes in the 10-year 
coronary heart disease risk. Data were collected on 10,739 Nebraska WISEWOMAN 
participants’ women between 2002 and 2004. Screening and rescreening results on age, 
race, education, residence, smoking status, disease history, medications and medical 
screening results for BMI, blood pressure, total cholesterol, and blood glucose were 
obtained. Feresu and colleagues found that age was the most significant factor in 
determining cardiovascular risk. Women aged 60 to 64 had a higher risk for high blood 
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glucose, blood pressure, and overweight/obesity. Women aged 50 to 59 and 60 to 64 
had higher rates of high blood pressure. The authors concluded that race, age, and 
residence were related to cardiovascular disease risk. This study highlights the 
effectiveness of screening in decreasing the burden of cardiovascular disease.  
The Massachusetts WISEWOMAN program conducted a randomized control 
study to assess the overall effectiveness of the WISEWOMAN program at reducing 
cardiovascular disease risk factors. Baseline data were collected between March and June 
1996 on blood pressure, total cholesterol, fruit/vegetable consumption, and exercise 
levels for 1443 women. The women were assigned to minimum intervention or enhanced 
intervention. Women in the minimum intervention received lifestyle interventions 
focused primarily on nutrition and physical activity to reduce risk of cardiovascular 
disease. The enhanced interventions included the latter, plus one on one nutritional and 
physical activity assessments and counseling, individual and group education, and 
behavioral intervention activities. Mixed model logistic regression analyses were 
conducted to test the overall effectiveness comparing change in the outcome variables 
over time, odds-ratios were not reported. The analysis results indicated that in both 
groups blood pressure decreased significantly; total cholesterol did not change 
significantly in either group; in both groups, fruit/vegetable intake increased. Women in 
the enhanced intervention group also had a statistically significant increase in physical 
activity. The study results indicated that cardiovascular disease screening and 
interventions are effective at reducing risk factors for cardiovascular disease.  
In an effort to assess the prevalence of obesity in low income African American 
and White women in North Carolina, Nelson et al. (2002) examined co-occurring risk 
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factors associated with coronary heart disease. There were 1284 White women and 754 
African American women included in the study. Among White women, 69% were 
overweight or obese and 87% of African American women were overweight or obese. 
Age, BMI, total cholesterol, self-reported diabetes, smoking, and 10 year coronary heart 
disease risk were analyzed using means and frequencies. Overall, obese (17.7%) and 
nonobese (13.3%) African-American women had three or more co-occurring risk factors 
for cardiovascular disease. Among White women, obese (26.9%) women had more co-
occurring risk factors than nonobese women (13%). This study is indicative of higher 
prevalence of co-occurring health risk factors for cardiovascular disease among African-
American women (p < .05). The authors concluded that more longitudinal studies are 
needed to solidify the effect of obesity on cardiovascular disease risk among African-
American and White women.   
The North Carolina WISEWOMAN program conducted a nonrandomized study 
to assess the overall effectiveness of the WISEWOMAN program in reducing 
cardiovascular disease risk factors. There were 31 local health departments in North 
Carolina selected, with 17 clinic sites conducting the minimum intervention and 14 
clinics conducting the enhanced interventions. Baseline data were collected on blood 
pressure, total cholesterol, fruit/vegetable consumption, and exercise level for 2148 
women. The women were assigned to minimum intervention or enhanced intervention. 
Women in the minimum intervention received lifestyle interventions focused primarily 
on nutrition and physical activity to reduce risk of cardiovascular disease. The enhanced 
interventions included the latter, plus three one-on-one nutritional and physical activity 
assessments and counseling, individual and group education, and behavioral intervention 
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activities. The results indicated that among the 2148 women screened, 40% had high 
total cholesterol, 63% had high blood pressure, and 76% were overweight or obese. 
Among the two groups, at the six month follow-up, change scores were calculated and 
the results revealed positive changes in total cholesterol, blood pressure, and BMI in both 
the enhanced intervention group and minimal intervention group (p < .05). There were no 
significant differences between the two groups and the results were not statistically 
different from the minimal intervention group. This suggests that any level of 
intervention is effective at reducing cardiovascular disease risk factors.  
Identifying Best WISEWOMAN Practices 
Parra-Medina, Wilcox, Thompson-Robinson, Sargent, and Will (2004) reviewed 
22 high-quality WISEWOMAN physical activity educational materials targeted at 
African-American WISEWOMAN participants. There were two expert panels and eight 
focus groups that evaluated the visual appeal and content of the educational materials 
used among the WISEWOMAN providers. Data were both quantitative and qualitative. It 
was concluded that the most appealing educational materials were those that were brief, 
colorful, simple, and applicable to the woman and her family. The authors recommended 
that the process could be replicated by other programs; however, the study’s primary 
limitations were that the women were all from the Southeast part of the United States and 
African-American.   
Farris, Will, Khavjou, and Finkelstein (2007) used Glasgow’s (2006) REAIM 
(reach, effectiveness, adoption, implementation, and maintenance) framework to assess 
the impact of 14 WISEWOMAN sites in North Carolina from 2001to 2003. Reach, 
efficacy/effectiveness, adoption, implementation, and maintenance identified high 
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performing and low performing sites. High performing sites have an extensive referral 
network, incentives, and lifestyle intervention protocols in place, on-going staff training, 
and evaluated yearly screening results of participants, while low performing sites do not. 
There were five high performing sites. The WISEWOMAN data collected helped assess 
cost-benefit and cost-effectiveness and provided appropriate outcome measurements to 
better define the impact of the WISEWOMAN program on reducing the burden of 
cardiovascular disease among women.   
Besculides et al. (2006) used the REAIM framework to explore best practices 
used by WISEWOMAN program to implement lifestyle intervention sessions that target 
risk factors for cardiovascular disease. There were five WISEWOMAN sites selected 
from 15 total sites. The five sites were selected based on project longevity and the 
availability of quantitative rescreening data for at least 100 women at 10 to14 months. 
Blood pressure, total cholesterol, BMI, and smoking status were assessed using a mixed-
method approach. Theme tables were drafted by researchers to identify best practices. An 
algorithm was applied to each theme to assess how frequently it was used across the five 
sites. There were 87 best practices identified. Of the best practices, 13 were used by high 
performing sites. High performing sites had an extensive referral network, incentives, and 
lifestyle intervention protocols in place, on-going staff training, and evaluated yearly 
screening results of participants. The identification of these best practices will assist in 
program implementation to identify successful factors for WISEWOMAN programs.  
Besculides et al. (2006) used the REAIM model and in-depth case studies to 
identify best practices for WISEWOMAN Programs. Five WISEWOMEN projects were 
included in the study and qualitative data was collected from each. More specifically, 
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semi-structured interviews were conducted with key informants and staff, while focus 
groups and observations were conducted with program participants. The overall goal of 
the study was to learn more about the best practices used to implement the program and 
the impact of the program on participants. All data was subject to thematic analysis and a 
standardized algorithm was used to identify how often certain practices were used by the 
program sites. Practices used most often by high-performing sites were considered best.  
Besculides et al. (2008) conducted a study to describe the best practices for 
implementing lifestyle intervention sessions used in the WISEWOMAN program. Using 
a mixed-method approach, Besculides et al. used the RE-AIM framework for 
WISEWOMAN site selection to classify and analyze qualitative data. Five project sites 
were selected. In order to classify best practices, an algorithm was designed that specified 
when only high performing sites used a practice; it was then considered best. When low 
performing sites used a practice, it was not considered best. If both low and high 
performing sites used a practice, a case study was conducted to explain the 
implementation method used. A total of 87 best practices were identified. A subset of 31 
best practices were used by high and low performing sites. These practices were further 
studied to identify the barriers to success among the low performing sites using the same 
practice as the high performing sites. The overall effectiveness was found to lie in staff 
training, use of incentives, having an implementation and evaluation plan, and the ability 
to adapt the plan as needed. This study identifies some of the key components in 
successful WISEWOMAN interventions. Using these data, other public health agencies 
can implement successful programs in their public health delivery.  
The WISEWOMAN program uses an integrated healthcare approach to deliver 
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lifestyle interventions. Goldstein, Whitlock, and Depue (2004) gathered evidence to 
assess the overall evidence related to the efficacy of intervention programs addressing 
physical activity, diet, obesity, cigarette smoking, and alcohol use/abuse. This was done 
using the United States Preventive Services Task Force (USPSTF), the United States 
Public Health Service (PHS), and conducting a literature review. The authors found that 
the most efficacious interventions were in the areas of physical activity, diet, smoking, 
and risky alcohol use. They recommended that interventions should have systems 
support, consist of a multidisciplinary team of trained staff, make referrals for patients 
needing more intensive treatment, and use a collaborative community approach. 
Intervention programs utilizing the 5 A’s approach of assess, advise, agree, assist, and 
arrange, have the most influence on lifestyle.  
Lewis et al. (2004) set forth to find out more about the methods used in North 
Carolina’s WISEWOMAN program and conducted an exhaustive review of literature to 
identify other methods of successful programs in order to identify project success stories 
from all the funded WISEWOMAN sites. The Alaska WISEWOMAN project was 
highlighted. There were 10 strategies used by the WISEWOMAN program in drafting a 
success story report. The 10 strategies included: identifying the target audience, develop a 
systematic process, develop a standardized form, collect success stories, conduct 
interviews, develop appealing format, write and revise stories, organize stories, design 
and print publication, and disseminate publication. WISEWOMAN Works was published 
in March 2003. The publication was used to educate staff about the WISEWOMAN 
program, shares lesson learned, raise program awareness, and identify challenges and 
opportunities. The success stories provide a venue for health promotion programs to 
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document success and evaluate program strengths/weaknesses and promote research-
based interventions. 
Cost Effectiveness 
The WISEWOMAN Workgroup, consisting of program directors, CDC project 
officers, and program staff, conducted an evaluation of the Massachusetts, Arizona, and 
North Carolina WISEWOMAN program. Data were obtained using the baseline 
screening, 6 months, and 12 months measures of blood pressure, total cholesterol, BMI, 
and physical activity from 4842 WISEWOMAN participants. The projects were divided 
into either enhanced intervention or minimum intervention groups. Risk factors for 
cardiovascular disease are common in all three states. Women in North Carolina (40%) 
and Massachusetts (40%) were more likely to have high total cholesterol; high blood 
pressure was more common among women in North Carolina (63%); women in Arizona 
were more likely to be overweight (83%). The authors concluded that more research 
needs to be conducted on cost-effectiveness in order to assess the long term effect on the 
reduction of risk factors using enhanced intervention method.  
In 2004, Finkelstein et al. conducted an assessment of the overall cost-
effectiveness of the WISEWOMAN program. Between June 2000 and December 2003, 
data were obtained using 3015 baseline and rescreening results at one year. Data 
collected included height, BMI, blood pressure, total cholesterol, and blood glucose 
levels. Program cost data were collected from the nine project sites for a 6 month period. 
Program cost included labor, outreach, screening, interventions, and materials. The 
average cost of providing WISEWOMAN activities was $270 per participant. 
WISEWOMAN participants significantly improved their ten year coronary heart disease 
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risk, including cholesterol and blood pressure. Smoking rates also decreased. All the 
improvements resulted in a $470 cost-effectiveness ratio for every percentage point 
reduction in coronary heart disease risk (p < .05). The authors concluded that the 
WISEWOMAN program is cost-effective and for every life year gained, there was $4400 
saved in direct and indirect costs. The analysis was limited in that the sensitivity analysis 
is subject to interpretation based on many different variables. There was also no control 
group involved in the analysis. 
Finkelstein, Troped, Will, and Palombo (2006) conducted an evaluation of the 
cost-effectiveness of the Alaska WISEWOMAN project. They found that the average 
cost of the intervention was $487 per women for a minimum intervention and $603 for an 
enhanced lifestyle intervention. It was estimated that for a full year of life gained, it save  
$5000 in direct and indirect costs. 
Hagberg and Lindholm (2006) conducted a literature review to assess the cost-
effectiveness of healthcare-based interventions aimed at improving physical activity. A 
total of 26 articles were found. The following variables were used to categorize the 
physical activity intervention programs: primary intervention method, study design, cost-
effectiveness ratios, and authors’ conclusion regarding cost-effectiveness. Exercise 
efficacy, population penetration, and adherence to physical activity were analyzed to 
assess the overall treatment effect. The prevention effect was measured using decrease in 
risk of future poor health. The overall health effect assessed the quality life years. The 
authors concluded that there are many cost-effective interventions targeted at high risk 
groups, such as the elderly and those with coronary heart disease. There is insufficient 
research regarding the cost-effectiveness of prevention-based interventions targeting 
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sedentary people.  
Other WISEWOMAN Programs  
In 1999, the South-central Foundation in Alaska was awarded WISEWOMAN 
funding. Alaska has designed and implemented a program specific to Alaska native 
women, called Traditions of the Heart. Stefanich et al. (2005) summarized the 
development, adaptation, and implementation of this program. Extensive formative data 
collection was conducted to ensure that the interventions met the needs of the Alaska 
Native women. Diet, physical activity, topics of interest, barriers, and preferred learning 
venue were collected via survey of 43 Alaska Native women aged 40 to 64. It was 
concluded that small group settings and programs that were sensitive to Alaska Native 
culture were best.   
Stfanich et al. (2005) also conducted a 12-week randomized pilot study, using 44 
women, to test the effectiveness of the intervention content, materials, and format. The 
women were assigned to the intervention or control group and a pre and posttests were 
used to assess behavior change. Following the pilot study, an overall program evaluation 
was conducted to determine whether the interventions were effective and relevant. 
Eighty- three percent of the participants felt that the intervention length, materials, and 
individual counseling sessions were effective. The information from the evaluation was 
used to make programmatic changes before broader scale implementation. The 
assessment tools were simplified and information regarding heart attack and stroke 
awareness were added to the curriculum. There were six overall themes identified by the 
authors as recommendations to other programs wanting to design intervention programs 
for specific populations. Those themes included: adapt current, research-based programs 
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to meet the needs of the target population; gather input from the target population and 
professionals serving the target population in the initial program planning; incorporate 
qualitative research into evaluation; use incentives; have a diverse strategic planning 
committee, and; use culturally appropriate materials.  
In a follow-up pilot study, the Alaska WISEWOMAN program conducted a pilot 
randomized control trial to assess feasibility and cultural acceptability, as well as to 
develop enrollment procedures. Four clinical sites were selected and data were collected 
between October 2000 and April 2001. Initial screening data (blood glucose, blood 
pressure, total cholesterol, and height/weight) were obtained to determine overall impact. 
There were a total of 76 women enrolled in the program. Of the 76 participants, 44 were 
randomized to the intervention group. Mean individual changes were assessed at 12 
weeks and women reported more physical activity and higher confidence in their ability 
to achieve regular physical activity. The results of the pilot study assisted in 
programmatic changes to better fit the Alaska Native population. The results of the pilot 
study suggest building on the strengths of the community and assist in refining 
population specific intervention programs.  
The Massachusetts WISEWOMAN program was one of three project sites 
initially funded by the CDC. In 1996, Finkelstein et al. conducted an evaluation of the 
cost-effectiveness of the WISEWOMAN project. A group randomized control study 
design was used to collect data from 11 WISEWOMAN sites over a one year period. 
Women were assigned to either an enhanced lifestyle intervention or minimum 
intervention. The effectiveness of the program was assessed using blood pressure, blood 
glucose, total cholesterol, BMI, age, and smoking status to assess the overall 10 year 
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coronary heart disease risk. The women in the minimal intervention group had a 9.4% 
CHD risk. The women in the enhanced lifestyle interventions group had 9.8% CHD risk. 
After one year, both groups had a slight decline in CHD risk (0.5 vs. 0.2). The authors 
concluded that the results were not statistically significant; however, the Massachusetts 
WISEWOMAN program made changes to program delivery. The WISEWOMAN 
program streamlined intervention delivery and standardized protocol in effort to 
minimize program implementation differences among projects.   
Feresu, Zhang, Puumala, Ullrich, and Anderson (2008) conducted a study to 
assess the overall 10 year CHD risk among Nebraska women enrolled in the 
WISEWOMAN program. Sociodemographic factors were examined in order to assess the 
relationship to CHD risk factors such as blood pressure, cholesterol, BMI, and diabetes. 
Between September 2002 and December 2004, a total of 10, 739 WISEWOMAN 
participant screening values were reviewed. Seventy-four percent of the women were 
located in rural areas; 54% were between the ages of 40 to 49; 83% were White; and 26% 
reported that they were current smokers. Sixty-six percent of the women had a previous 
diagnosis of high blood pressure, high total cholesterol or diabetes. The overall incidence 
rate of obesity was 44 out of 1000. The incidence rate for hyperglycemia was 31 out of 
1000. The overall incidence rate for hypertension was 66/1000, while there was an 
incidence rate of 157 out of 1000 for high total cholesterol. Women aged 60 to 64 were 
most at risk for obesity, high total cholesterol and hyperglycemia. Women aged 50 to 59 
were most at risk for high blood pressure. A total of 3416 women had both baseline and 
follow-up data, which indicates a barrier to follow-up sessions. Women that attended one 
versus two follow-up sessions were more likely to have hyperglycemia (6.86% vs. 
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4.96%) and high total cholesterol (19.99% vs. 19.47%) (p = .05). This study suggests 
that sociodemographic factors increase risk of CVD among Nebraska WISEWOMAN 
participants. It also indicates the need to enhance intervention reach in order to increase 
follow-up sessions.  
In 2004, Staten et al. conducted research on the Arizona WISEWOMAN program 
using an experimental design. This study’s main purpose was to track the effectiveness of 
WISEWOMAN in increasing physical activity and fruit and vegetable consumption over 
a 12-month period. Three levels of intervention were used. Low intensity consisted of 
provider counseling. The second level of intensity included health education classes and a 
monthly newsletter, while the third level also included social support by community 
health workers. The study population consisted of Hispanic women, age 50 to 64, and 
data consisted of height, BMI, and blood pressure measurements. Participants were also 
asked to recall their diet over the last 24 hour period. Linear regression models were used 
to compare changes between the two groups, as well as interaction effects for the 217 
women included in the analysis. The results indicated that overall, women in all three 
intervention groups demonstrated positive change and increased the number of minutes 
of moderate to vigorous physical activity over one year. Women in the most intensive 
intervention group increased fruit and vegetable consumption, compared with participants 
who only received the level one or level two intervention (p < .05).  
Staten and colleagues (2004) demonstrated the effectiveness of lifestyle 
intervention sessions in reducing cardiovascular disease risk factors; however, it lacked 
statistical power to interpret significant change between the groups. Furthermore, the 
sample size was very small, relative to the population served and finally, self-report diet 
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recall was also subject to bias.  
In a follow-up study on the Arizona WISEWOMAN project, Gregory-Mercado et 
al. (2007) compared the 24-hour dietary recalls of Hispanic and nonHispanic White 
women enrolled in the program. Individual nutrient intakes were compared by the 
sociodemographic background characteristics thought to influence diet and predispose 
them to unhealthy eating. There were 260 Hispanic women and 88 White women in the 
sample. Nutrient intake including total caloric intake, total protein, total carbohydrate, 
total fat, cholesterol, and total dietary fiber was assessed among the two groups.  
Hispanic women had a significantly lower intake of energy intake than White 
women. The comparison by the percent of calories from macronutrients indicated no 
difference; however, micronutrient intake was lower for Hispanic women. Both Hispanic 
and nonHispanic Whites were lacking in calcium intake. A higher intake of protein and 
potassium were associated with higher BMI and vitamin E and folate intake were 
associated with smoking. This study was based on self-reported dietary recall. The small 
sample size is also a limitation of this study. This study provides information useful to 
nutrition education programs targeting low-income, uninsured Hispanic women.  
Oleson, Breheny, Pendergast, Ryan, and Litchfield (2008) conducted research on 
the Iowa WISEWOMAN participants to examine the impact of travel distance to an 
intervention session on overall intervention attendance. There were 787 women involved 
in the randomized control trial from October 2002 to July 2005. Driving distances were 
classified as rural or urban locations. An additive model suggested that distance from the 
intervention site was more of an issue for women residing in a rural area than those 
residing in an urban setting. Among women in an urban setting, 57.6% attended an 
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intervention session, while 53.8% of woman in a rural setting attended an intervention 
session. Also, women that were more educated, had health insurance, exercised less, had 
higher BMI, did not smoke, enrolled earlier, and had smaller families were more likely to 
attend the intervention sessions (p < .01). This study illustrates the overall impact of 
distance traveled on the probability of attending the WISEWOMAN intervention 
sessions. This research suggested that feasibility of participant travel to intervention 
sessions is an important factor to consider when planning WISEWOMEN programs in 
rural versus urban areas.  
The North Carolina WISEWOMAN program has an enhanced lifestyle 
intervention program that addresses behavior changes based on the chronic care model, 
including environmental and individual factors in a clinical setting. In an effort to 
evaluate the enhanced intervention’s effectiveness, Jilcott et al. (2006) conducted a 
randomized trial from May 2003 to December 2004 to compare changes in moderate 
intensity physical activity and diet at the baseline level. A total of 204 participants were 
randomly assigned to control or enhanced intervention groups. Blood pressure, blood 
glucose, BMI and waist circumference, and total cholesterol were also assessed. Blood 
pressure was higher among the minimal intervention group than among those in the 
enhanced intervention group. Both groups had participants with high BMI (75%) and 
25% of the total sample were current smokers. There was no significant difference in 
dietary consumption between the two groups. The enhanced and minimal intervention 
groups (40%) reported neighborhood characteristics as barriers to physical activity and 
healthy diet.  
These initial data suggested the need for community linkages to facilitate healthy 
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behavior change. The Neighborhood Assessment and tip sheet, developed by the North 
Carolina WISEWOMAN program, facilitates community development and encourages 
policy change to improve community and environmental factors influencing health 
related behavior. Although this study only reports initial screening results, it is useful to 
other programs interested in developing a strategic plan to address environmental barriers 
to physical activity and healthy diet.  
Keyserling et al. (2008) conducted a randomized trial to assess the impact of 
enhanced versus minimal WISEWOMAN intervention sessions on physical activity and 
diet. From May 2003 to December 2004, 236 WISEWOMAN eligible women were 
assigned to either enhanced intervention or minimal intervention sessions. The enhanced 
interventions (EI) took place over 6 months and were comprised of two individual 
counseling sessions, three group sessions, and three phone counseling sessions, followed 
by a maintenance phase that consisted of one individual counseling session and seven 
monthly phone counseling sessions. The minimal intervention (MI) sessions included a 
one-time mailing of informational pamphlets pertaining to diet and physical activity.  
Measurements were taken at 6 months and 1 year using an accelerometer to track 
activity minutes, the Dietary Risk Assessment (DRA) to assess dietary intake of fruits 
and vegetables, and a self- assessment of physical activity. Keyserling et al. (2008) used 
descriptive statistics and outcomes were measured using ANCOVA. It was found that 
there was no statistical difference in accelerometer measurements at both 6 and 12 
months between the EI (M = 30.6, SE = 0.5) and MI (M = 29.9, SE = 0.4) groups; the 
DRA score for side dishes (which was inclusive of fruit and vegetable intake) decreased 
more at six months for the EI group (M = 7.7, SE = 0.2) than for the MI group (M = 8.8, 
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SE = 0.2), which was statistically significant. However, at 12 months there was no 
difference in scores among the EI (M = 8.0, SE = 0.3) and MI (M = 8.4, SE = 0.3) groups. 
The self-report physical activity scores from the EI baseline (M = 29.4, SE = 0.8) to 12 
months (M = 30.0, SE =0.7) increased. The opposite effect was demonstrated among the 
MI group baseline (M = 29.2, SE = 0.8) and 12 month (M =28.4, SE = 0.6) scores. All 
values were age adjusted. The limitations of this study include the relatively small sample 
size and the self-report assessment; however, this study demonstrates the overall 
effectiveness of enhanced interventions in addressing barriers to healthy behavior change. 
Introduction to South Dakota WISEWOMAN 
South Dakota has administered a WISEWOMAN program called All Women 
Count! (AWC!) since 2000. AWC! also includes the state’s Breast and Cervical Cancer 
Early Detection Program (BCCEDP). WISEWOMAN and BCCEDP are integrated in 
South Dakota; the result is a comprehensive chronic disease screening and prevention 
program that has served thousands of the state’s most at-risk and medically underserved 
women (South Dakota WISEWOMAN, 2008). With continued funding for AWC! from 
the CDC the South Dakota Department of Health has built on its successful beginnings. 
The program remains committed to its three central objectives: (a) maximizing reach by 
serving as many eligible women as possible statewide; (b) maximizing integration 
between WISEWOMAN and BCCEDP so as to create a unified project that is as patient-
friendly, provider-friendly, and cost-efficient as possible; and (c) maximizing outreach to 
the state’s most underserved women (including the large American Indian population).  
The AWC! program brings WISEWOMAN and BCCEDP under a single 
leadership team so that the recruitment and marketing efforts of both projects 
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complement one another. In this way, the marketing exposure of both projects is 
maximized. Methods of recruitment include word-of-mouth from providers, family, and  
friends, as well as radio, television, newspaper, Internet, posters, and booths at 
community health fairs and other activities (South Dakota WISEWOMAN, 2008). 
The screenings are provided at 267 provider sites; AWC! provides 
WISEWOMAN-standard screening services to women across the state of South Dakota. 
The great majority of screening providers are private practitioners. AWC! elected to 
support such a large network of provider sites in order to overcome the barriers to 
participation associated with South Dakota’s extreme rurality. 
In 2005, a study on the maintenance of healthy eating and physical activity among 
the WISEWOMAN participants in South Dakota was conducted. Fahrenwald (2005) 
examined the maintenance of healthy eating and physical activity behaviors beyond the 
six month post counseling period and examined the barriers and facilitators of healthy 
behaviors. A process evaluation survey research design was used. There were 72 SD 
WISEWOMAN participants included in the study that completed a 15 minute telephone 
interview. Of the 72 interviews, 69 women received at least one face-to-face physical 
activity or dietary counseling session.  
At the first follow-up (less than 6 months from baseline screening), more than 
60% of the participants in this study maintained changes in healthy eating and 
improvements in healthy eating behavior were maintained by 65% of the women who 
reported that they were eating a heart healthy diet. Improvements in physical activity 
were maintained by 70% of the women who reported that they were regularly active at 
the first follow-up period. Seven facilitators of healthy behavior were identified 
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including: educational knowledge and awareness, the AWC! program, family 
support, personal health conditions, family health issues, cooking healthy foods, and 
feeling better. Barriers to healthy behavior maintenance included cost of healthy foods, 
personal preference for less healthy foods, time, eating out, cooking for others, 
availability of garden produce, and rural access to healthy choices. Four facilitators to 
maintenance of regular physical activity were identified. Those included support from 
others, enjoyable activity, occupational activity, and knowledge of the benefits of 
physical activity. Common barriers to physical activity maintenance included access, 
cost, personal health issues, time, weather and motivation.  
The Women’s Prison in Pierre, SD, is one of the NBCCEDP sites where the 
WISEWOMAN program trained prison staff to provide heart disease risk factor 
screenings and lifestyle interventions to incarcerated women beginning in 2004. The 
prison setting offers an opportunity to initiate a heart disease risk factor screening and 
intervention program in an environment conducive to high levels of participation, but low 
level of control in relation to physical activity and nutrition.  
In 2005, Khavjou et al. (2007) conducted an analysis to assess the baseline heart 
disease risk profile of WISEWOMAN participants screened in the SD state prison and 
compared it with that of the general WISEWOMAN population of low-income, 
uninsured women in SD. Baseline prevalence of heart disease risk factors (hypertension, 
high cholesterol, smoking, and obesity) were assessed among incarcerated women in SD 
relative to the general WISEWOMAN population in SD from January 2004 to 2005. 
There were a total of 261 women in the SD state prison and 1,427 nonincarcerated 
women. The WISEWOMAN program also collected detailed information on each 
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lifestyle intervention session attended by the participants (intervention date, 
intervention setting, and contact type). The results indicated that there were a 
significantly higher percentage of incarcerated women (84.6%) than nonincarcerated 
women (53.6%) with high total cholesterol who were unaware of their condition. 
Incarcerated SD WISEWOMAN participants attended an average of two lifestyle 
intervention sessions, whereas nonincarcerated women attended an average of 0.4 
sessions. Intervention take-up rates were 53.3% among incarcerated women and 22.6% 
among nonincarcerated women. Intervention completion rates were 42.5% among 
incarcerated women and 3.6% among nonincarcerated women (p < .01).  
The results of this analysis illustrate a need to implement heart disease screening 
and education programs, such as WISEWOMAN, in prisons. Specifically, screenings 
help to identify cases of abnormal blood pressure and total cholesterol that otherwise 
would go undiagnosed. Lifestyle interventions also provide an opportunity for 
incarcerated women to acquire knowledge and skills for developing healthier diets, 
increasing physical activity, and quitting tobacco use. Moreover, programs like 
WISEWOMAN have the potential to improve discharge planning and linkages between 
released women and community service.  
This study cannot state with certainty whether the observed differences between 
incarcerated and nonincarcerated women were the result of differences between the two 
groups that existed before the women entered the prison system or whether they were 
caused by the incarceration period. 
Lifestyle Intervention Effectiveness 
Lifestyle intervention sessions and intervention programs that are tailored 
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according to a woman’s readiness to change, culture, age, location, and access are a 
promising approach to improving the cardiovascular health of low-income uninsured 
women. Lifestyle interventions also provide an opportunity for underinsured women to 
acquire knowledge and skills for developing healthier diets, increasing physical activity, 
and decreasing tobacco use (South Dakota Department of Health, 2008). Moreover, 
programs like WISEWOMAN have the potential to improve linkages between women 
and community service providers (South Dakota Department of Health, 2008). A heart 
disease screening and intervention program is a promising strategy for reducing the 
burden of cardiovascular disease among women in the United States (South Dakota 
Department of Health, 2008). Many of the intervention programs used have a theoretical 
construct based on behavioral change models such as the health belief model, the 
transtheoretical model of change, and the socioecological model (South Dakota 
Department of Health, 2008). Many programs use motivational interviewing to identify 
individual risk-level, behavioral goals, and readiness to change (South Dakota 
Department of Health, 2008). An individual’s readiness to change then determines the 
intensity and emphasis of the intervention program and the strategies that will be utilized 
to promote sustainable lifestyle changes (South Dakota Department of Health, 2008). 
Lifestyle intervention programs targeting high blood pressure, blood glucose, and 
cholesterol are very successful in that they can provide free and/or reduced cost 
medication to control the elevated levels, while also focusing on individual behavior 
change and support. There is also diversity in the literature in terms of the intensity of the 
intervention (Ash et al., 2006; Feigenbaum et al., 2005; Jacobs et al., 2004; Keyserling et 
al., 2008; Lewis et al., 2004; Logue et al., 2005; Nelson et al., 2002; Pazoki et al., 2007; 
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Staten et al., 2004; Svetkey et al., 2008). The empirical evidence suggested that such 
intervention can be effective (Ash et al., 2006; Besculides et al., 2008; Feigenbaum et al., 
2005; Goldstein et al., 2004; Logue et al., 2005; Opdenacker et al., 2008; Pazoki et al., 
2007; Svetkey et al., 2008). Individual support and lifestyle interventions that are 
primarily focused upon reduction in BMI or weight loss are producing promising results 
as well, although reduction in BMI is not as pronounced as seen in blood pressure, blood 
glucose, and total cholesterol (Will & Loo, 2008). More research is needed in this area to 
determine what factors contribute to the positive effects of such interventions over an 
extended period of time.    
Summary of Methodological Differences in WISEWOMAN Studies 
 Currently, eight studies have been reported, seven were randomized control trials 
and one was a case control study. All studies used the same biomarkers as dependent 
variables. Currently, there has not been any previous study has been a quasi experiment 
demonstrating how well the program works when translated into real-world practice.   
Of the eight total WISEWOMAN studies that focused on change in biomarkers, 
six of them demonstrated positive results in that the interventions were effective. The 
methods used in previous WISEWOMAN studies differ greatly based on location, sample 
size, demographics, random assignment, intervention intensity, longevity and funding 
level, as well as the overall analysis.  
Summary and Conclusion 
The results of the research highlighted above illustrated a need to implement heart 
disease factor screening and education programs, such as WISEWOMAN, into state 
health departments in effort to expand the reach of the program and identify and serve 
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more at-risk women. Specifically, screenings help to identify cases of abnormal blood 
pressure and total cholesterol that otherwise would go undiagnosed. Lifestyle 
interventions also provide an opportunity for underinsured women to acquire knowledge 
and skills for developing healthier diets, increasing physical activity, and quitting tobacco 
use. Moreover, programs like WISEWOMAN have the potential to improve linkages 
between women and community service providers. A heart disease screening and 
intervention program is a promising strategy for reducing the burden of cardiovascular 
disease among women in the United States.  
WISEWOMAN research has supported the effectiveness of the screening sessions 
and lifestyle interventions in preventing chronic disease at 10 to14 months; however, no 
studies have quantitatively examined whether LSI sessions and screenings or clinical 
screenings alone lead to improvements in blood pressure, blood glucose, total cholesterol, 
and/or BMI. There is also a gap in the research related to WISEWOMAN facilitated 
maintenance of health behavior beyond the 10 to14 month follow-up screening. In 
addition, not enough is known about the effectiveness of lifestyle change programs in 
populations containing substantial numbers of American Indians. The purpose of this 
retrospective longitudinal study was to quantitatively examine whether LSI sessions and 
screenings or clinical screenings alone lead to improvements in blood pressure, blood 
glucose, total cholesterol, and/or BMI in an especially vulnerable group.
  
CHAPTER 3: 
RESEARCH METHODS 
Introduction 
This chapter provides a description of the research methods used in this 
dissertation. The purpose of the study, research design and approach, conceptual and 
measurement models, statistical methods, as well as protection of human subjects is 
reviewed in chapter three. Cardiovascular disease and risk factors leading to 
cardiovascular disease disproportionately affect women in certain South Dakota 
populations, such as ethnic minority populations and those from low-income 
backgrounds, who have a greater burden of chronic disease and lifestyle related risk 
factors.  
Maintenance of health behavior change is a public health challenge, particularly 
for those populations suffering from health disparities. While the quality of life and 
chronic disease risk reduction benefits of healthy eating and regular physical activity are 
well understood, the ability to promote adherence to a lifetime of these health behaviors 
is limited (Institute of Medicine, 2001). The major problem is that while intervention 
strategies that lead to adoption of healthy behaviors are well-developed, our knowledge 
of how to facilitate sustained health behavior is poorly understood. More research is 
needed in this area if health disparities among the South Dakota WISEWOMAN 
population are to be reduced or eliminated.  
This research elucidated whether health outcomes among women who attend a 
combination of LSI sessions and clinical screenings or clinical screenings alone lead to 
statistically significant improvements in blood pressure, blood glucose, total cholesterol, 
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and/or BMI as measured at rescreening 10 to14 months from initial screening. 
Understanding which method (screenings sessions alone or screening sessions along with 
LSI) has the greater influence on biological outcomes, influences the design of more 
effective public programs aimed at improving the health in population groups similar to 
those served in South Dakota.   
The purpose of this retrospective longitudinal study was to quantitatively examine 
whether the combination of LSI sessions and clinical screenings or clinical screenings 
alone lead to improvements in blood pressure, blood glucose, total cholesterol, and/or 
BMI as measured at rescreening 10 to14 months from initial screening.  
Research Design and Approach 
This quantitative retrospective longitudinal study examined whether the 
combination of LSI sessions and clinical screenings or clinical screenings alone lead to 
improvements in blood pressure, blood glucose, total cholesterol, and/or BMI as 
measured at rescreening 10 to14 months from initial screening. The independent variable 
was participation in screening session and Lifestyle intervention sessions or only 
screening sessions. The dependent variables were blood glucose, blood pressure, total 
cholesterol, and BMI. This dissertation study used secondary data and as such, the 
researcher did not have any contact with participants; she only used previously collected 
data for analysis. 
It was assumed that, within the context of this research study, all participants were 
South Dakota female residents that met the age and income requirements for program 
enrollment. However, to assess this assumption age was examined in the data analysis. It 
was also essential to assume that the lab results and measurements of blood pressure, 
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blood glucose, BMI, and total cholesterol were accurate, as all clinics receive on-going 
training and follow the guidelines set forth by the program.  
The conceptual model for the study is shown in Figure 2. The diagram model is 
based on the socioecological model. Outcome biomarkers were hypothesized to be 
determined primarily by baseline values of the same measures. Health behaviors also 
affect biomarkers at follow-up, as do social and demographic factors. The intervention 
sessions were expected to impact the rescreening results among the women and therefore 
it was logical to assume that the interventions produce positive change among 
participants. 
 
 
 
 
 
 
 
 
 
Conceptual Model for the Study
Group: LI or Screening
Behavioral Risk Factors at Baseline
Socio-demographic: marital status, age, 
employment, and education
Biological: baseline values for blood glucose,
blood pressure, total cholesterol, and BMI
Outcome values for blood
glucose, blood pressure,
total cholesterol, and 
BMI
Behavioral Risk Factors
after intervention
 
Figure 2. Conceptual model for the study.  
The conceptual model has been converted into a measurement model that drives 
the analysis of the data (Figure 3). The effects of baseline values of the biomarkers were 
controlled using change scores. The interventions were assumed to affect change in 
  
 
56
biomarkers independently. Social and demographic variables were used to adjust for 
potential confounding that arose because of their effects via unmeasured health 
behaviors. The relationship between socio-demographic variables and behavioral change 
is shown as a dashed line because it is unmeasured.   
 
Measurement Model for the Study
GROUP: LI or 
Screening Only
SOCIO-DEMOGRAPHIC: 
marital status, age, 
employment, education
Change in 
biomarkers: blood 
glucose, blood 
pressure, 
cholesterol, BMI 
 
 
 
 
 
 
 
 
Figure 3. Measurement model for the study.  
Study Limitations 
The lack of a random sample weakened external validity. Not using random 
assignment of subjects to groups weakens internal validity, as does omission of health 
behavior variables. The women self-select and without randomization to groups, it is 
difficult to discern the extent to which the intervention attendance truly impacted the 
outcomes.  
Participant Inclusion/Exclusion Guidelines 
Eligible participants included 653 low income women aged 30 to 64 enrolled in 
the South Dakota AWC! program from 2000 to 2005 that participated in both the 
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screening and rescreening 10 to14 months later. There were a total of 423 in the 
screening session only cohort and 230 in the intervetnion cohort. The women in the 
intervention cohort had to attend a minimum of one LSI session to be included in the 
intervention cohort. There were 69 women who did not have any elevated or alert levels 
for blood pressure, blood glucose, cholesterol and/or BMI. The inclusion criteria included 
South Dakota women aged 30 to 64 that met WISEWOMAN income guidelines for 
enrollment. The income guidelines are set by the Health and Human Services (HHS) and 
SD uses the 200% poverty level. The age guidelines were set by the CDC. South Dakota 
has been allowed to include women beginning at age 30 because of the smaller 
population base. In order to reach the number of women that the CDC mandates states to 
screen, South Dakota was granted permission to decrease the age for inclusion. The upper 
limit for inclusion was 64 years of age. This was because at age 65 a person is eligible for 
Medicare Part B. The exclusion criteria included nonSouth Dakota residents that did not 
meet enrollment guidelines and those who were not recreened 10 to14 months after initial 
screening. There were not any women excluded from this study because of ineligibility.  
Sample Size 
A power analysis was conducted to determine the minimum number of 
participants needed in this study to detect statistical significance (Cohen, 1988). Several 
models were examined using simultaneous multiple regression. All models tested 
whether the independent variables (group, age, work status, full-time work status, marital 
status, number of dependents, education, income, race, ethnicity, smoking status) 
predicted the four dependent variables (change in blood pressure, change in BMI, change 
in total cholesterol, and change in blood glucose). A medium effect size was chosen for 
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the power analysis based on what had been found in previous WISEWOMAN 
evaluations and what was considered clinically relevant. The α for the test of this model 
was set at .05. To achieve power of .80 and a medium effect size (f 2=.15), a sample size 
of 123 was required to detect a statistically significant regression model (F (11,111) = 
1.87). The existing sample size of 653 women provided 100% power to detect 
significance (F (11, 641) = 1.80. The study had enough statistical power to detect an 
effect, given that the effect actually exists. 
Study Procedures 
 This dissertation study used a census sample of all WISEWOMEN participants 
from 2000 to 2005. The data is obtained at initial screening and then at rescreen for 
women enrolled in the SD WISEWOMEN program. The method of inquiry used was to 
query the WISEWOMEN database that is developed and maintained by MAX TRAC 
Data Systems, Inc. located in Minneapolis, MN. MaxTrac has been South Dakota's data 
management contractor since 1997. The MaxTrac system provides a secure method of 
maintaining and tracking participants, decreasing loss to follow up. This dissertation 
study used secondary data analysis to assess change scores in blood pressure, BMI, blood 
glucose, and cholesterol among SD WISEWOMAN participants.  
Instrumentation  
The dependent variables in this dissertation study were change in BMI, change in 
total cholesterol, change in blood pressure (both systolic and diastolic), and change in 
blood glucose level. These variables have previously been shown to be valuable 
indicators of cardiovascular disease risk and have been used in evaluations of lifestyle 
interventions, as shown in the literature review for this study. Independent variables 
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included items drawn from the AWC! assessment form, which addresses the 
participant’s personal health history. Information requested included information about 
demographic variables such as age, race, marital status, ethnicity, education, 
employment, and insurance status. The researcher, the state of South Dakota’s chronic 
disease epidemiologist, serves the SD WISEWOMAN program and is directly involved 
with data analysis and program evaluation, therefore having access to all WISEWOMAN 
data.   
Data Recoding 
 The strategy for recoding each variable included in the analysis can be found in 
Table 2 and Table 3. 
Table 2 
Recoding of Independent Variables 
Variable Measure Recoding 
Age Age in years  Recoded Based upon distribution (18-34.9, 
35-49.9, 50-64.9, 65 and over)   
Marital Status Married/Not Married  the unmarried categories were combined  
Work Status Employed? (Yes/No)  the unemployed categories were combined 
Full-time work 
Status  
Works full time (Yes/No)  None 
Income  Yearly household income in dollars  Was recoded into categorical variables 
based on quartiles  
Education  Highest education completed  Less than HS, High school degree, 2-yrs 
post HS, 4-year college degree or more. 
Dependents  # of dependents in the household  None 
Race Asian, Black, American Indian, White, Other Was recoded into White, American Indian, 
and Other  
Ethnicity Hispanic (Yes/No)  None 
Group Participation in LSI (Yes/No)  None 
Smoking Status  Do you smoke (Yes/No) None 
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Table 3 
Recoding of Dependent Variables 
Variable Measure Recoding 
blood glucose change in blood glucose from pre-posttest.  Blood glucose at follow-up –blood glucose 
at intake  
blood pressure change in systolic blood pressure from pre-
posttest.  
Systolic blood pressure at follow-up –
systolic blood pressure at intake 
blood pressure change in diastolic blood pressure from pre-
posttest.   
Diastolic blood pressure at follow-up – 
diastolic pressure at intake 
 
 
Total cholesterol change in total cholesterol from pre-posttest. Total cholesterol at follow-up - total 
cholesterol at intake   
Body Mass Index change in BMI from pre-posttest.  BMI at follow-up - BMI at intake 
 
Statistical Analysis 
Data were obtained from MaxTrac in Excel spreadsheets and imported into SPSS 
15.0. The data were cleaned and any outliers were identified and removed. Data were 
recoded as necessary, especially in cases of skewness. Descriptive statistics (e.g., mean, 
standard deviation for continuous variables, frequency, and percentages for categorical 
variables) were computed for each variable. Change scores were computed for all 
dependent variables (change in blood glucose levels, change in BMI, change in total 
cholesterol levels, change in blood pressure). Pearson correlation was used to examine 
the degree of association between the continuous independent and dependent variables 
(e.g., age and blood pressure). The association between the dependent variables and the 
categorical variables were examined using ANOVA unless variances were unequal, in 
which case the Kruskal-Wallis analysis of ranks was employed. 
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Multiple linear regression analysis was used to examine the research questions 
and corresponding hypotheses. The first regression model examined the ability of the 
independent variables (group, age, work status, full-time work status, marital status, 
number of dependents, education, income, race, ethnicity, smoking status) to predict 
change in blood glucose levels. The second regression model examined the ability of the 
independent variables to predict change in BMI. The third regression model examined the 
ability of the independent variables to predict change in total cholesterol levels. The 
fourth and final regression model examined the ability of the independent variables to 
predict change in blood pressure. The regression models were run for those women who 
had elevated or alert blood pressure, blood glucose, total cholesterol, and/or BMI levels at 
the initial screening session. The elevated value for blood pressure is classified as 
>140/90 but <180/110 mm Hg, while an alert value is >180/110 mm Hg. The elevated 
value for total cholesterol is >= 200 mg/dl, while the alert value is >= 400mg/dl. The 
elevated value for blood glucose (Fasting Plasma Glucose Test) is >= 126mg/dl, while 
the alert value is >= 200 mg/dl. A BMI between 25 and 29.99 is classified as overweight, 
while a BMI of 30 or above is classified as obese or alert value includes blood pressure 
greater or equal to 140 systolic and/ or 90 diastolic (140/90), total cholesterol 200 mg/dl 
or greater, blood glucose 126 or greater, and BMI of 25 or greater. The modeling strategy 
retained all predictors in the equations. If the confidence interval was excessively broad 
for a particular coefficient, the variable was recoded to reduce sparseness in the data. If 
the model was unstable, variables with high p values were dropped. Quadratics were 
entered to test for nonlinear relationships.  
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Protection of Human Subjects 
The raw data were provided to the researcher from MaxTrac, the contracted data 
manager for the SD WISEWOMAN program. The researcher was able to obtain those 
data because of her position as the Chronic Disease Epidemiologist (serving as 
epidemiological support for the SD WISEWOMAN program) for the South Dakota 
Department of Health. Those data did not include any unique identifying information 
such as names or addresses. To protect the rights of human subjects, institutional review 
board approval was sought at Walden University before any data analysis began. This 
dissertation study used secondary data and as such, the researcher did not have any 
contact with participants; she only used previously collected data for analysis.  
In the original study on which this dissertation is based, all participants completed an 
informed consent form prior to participating in the intervention. The original consent 
form explained the purpose of the study, the potential risks, the voluntary nature of 
participation, and procedures to ensure participant confidentiality. The data were 
analyzed and results were reported at the group level. The CDC does not require 
additional IRB approval for the release of these data. The CDC, as well as the South 
Dakota Department of Health have already granted permission to use existing 
quantitative clinical data from 2000 to 2005.The dataset OMB number is 0920-0612 at 
CDC and it is a nonresearch dataset, so IRB approval is not needed.  
All study records were kept private. Any report the researcher might publish will 
not include any information that could make it possible to identify the study participants. 
No names were used in any reports or publications generated from this dissertation and 
all data were reported at the group level. The electronic data files were kept in a password 
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protected file on a password-protected computer located in the researcher’s office and 
data files will be saved for up to seven years; only the researcher has access to these files.  
 
  
CHAPTER 4: 
RESULTS 
Purpose of the Study 
 The purpose of this retrospective longitudinal study was to examine quantitatively 
whether the combination of LSI sessions and clinical screenings or clinical screenings 
alone lead to improvements in blood pressure, blood glucose, total cholesterol, and/or 
BMI as measured at rescreening 10 to 14 months from initial screening. This study 
provided information to the SD WISEWOMEN program regarding the effectiveness of 
LSI support for clinical screening as opposed to clinical screening alone to improve 
health. The data obtained influence future program implementation decisions and serve as 
a model of WISEWOMAN program evaluation for the CDC. 
Research Questions and Hypotheses 
The primary research questions that were addressed in this dissertation include:  
 1. Is the change in blood glucose level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screenings 
only? 
 2. Is the change in BMI, as measured at rescreening 10 to14 months from initial 
screening, different for women enrolled in the South Dakota WISEWOMAN program 
lifestyle intervention than women receiving clinical screenings only? 
 3. Is the change in total cholesterol level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screenings 
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only? 
 4. Is the change in blood pressure level, as measured at rescreening 10 to14 
months from initial screening, different for women enrolled in the South Dakota 
WISEWOMAN program lifestyle intervention than women receiving clinical screenings 
only? 
 This chapter provides the results of the data analysis. The results are presented in 
the following order: sample descriptive statistics for the entire sample, univariate, and 
multivariate findings; descriptive statistics for the elevated sample only, univariate, and 
multivariate findings. High blood pressure is defined as having systolic blood pressure 
equal to or greater than 140 mmHg or diastolic blood pressure equal to or greater than 90 
mmHg, or taking medication for high blood pressure. High cholesterol is defined as 
having total cholesterol equal to or greater than 240 mg/dl or taking medication for high 
cholesterol. Overweight is defined as having a BMI of 25 to 29.9, while obese is defined 
as having a BMI equal to or greater than 30. BMI is calculated using CDC standards: 
BMI = (weight in pounds) divided by (ht in inches squared) times (703). Prediabetes is 
defined as a fasting blood glucose of 100 to125mg/dl or a nonfasting glucose of 140 to 
199 mg/dl. Diabetes is defined as a fasting blood glucose equal to or greater than 
126mg/dl or a nonfasting glucose equal to or greater than 200 mg/dl or history of diabetes 
or taking medication for diabetes. The LSI sessions offer women with elevated or alert 
screening values up to four lifestyle interventions. The elevated value for blood pressure 
is classified as >140/90 but <180/110 mm Hg, while an alert value is >180/110 mm Hg. 
The elevated value for total cholesterol is >= 200 mg/dl, while the alert value is >= 
400mg/dl. The elevated value for blood glucose (Fasting Plasma Glucose Test) is >= 
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126mg/dl, while the alert value is >= 200 mg/dl. A BMI between 25 and 29.99 is 
classified as overweight, while a BMI of 30 or above is classified as obese or alert value 
includes blood pressure greater or equal to 140 systolic and/ or 90 diastolic (140/90), total 
cholesterol 200 mg/dl or greater, blood glucose 126 or greater, and BMI of 25 or greater. 
Replacement of Missing Values  
Missing values for independent variables that were measured on either a nominal 
or ordinal scale were replaced. Specifically, the median was used to replace the missing 
values. There were only seven cases with missing data. No comparisons were made 
between this subset and the entire sample. Replacement of missing values was 
implemented to be in compliance with other WISEWOMAN research studies.  
Univariate Test Results 
WISEWOMAN Lifestyle Intervention and the Independent Variables 
 Univariate tests for the independent variables are presented below.  
 BMI. The means and standard deviations for the BMI change scores across 
conditions, control (screening session only) vs. intervention (screening sessions with 
lifestyle intervention sessions) and BMI categories (i.e., overweight, obese, and morbidly 
obese) are displayed in Table 4. As can be gleaned from Table 4, the mean BMI change 
score for participants classified as overweight (in both control and intervention groups) 
was negative. The mean change score for participants classified as obese was negative 
only for those in the control group but was positive for those in the intervention group. 
Across both groups, the mean change score for participants classified as morbidly obese 
was positive.  
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The findings in Table 5 reveal that, first, BMI change scores did not vary 
significantly across conditions (F (1,453) = 2.509, p = .114). The mean change score of 
the control group (M = .05) was similar to the mean change score of the intervention 
group (M = .25). Second, there was a significant main effect for BMI categories (F 
(1,453) = 4.727, p = .009). Post-hoc Tukey test procedures reveal that the BMI change 
scores of overweight participants varied significantly (M = -.29) from the change scores 
of obese participants (M = .25; p = .046). Third, the effect of the intervention on BMI 
change scores did not vary across BMI categories (F (2,453) = 1.625, p = .198).  
Table 4 
Means and Standard Deviations of BMI Change Scores (N = 454)  
BMI Category Control Intervention 
 Mean SD Mean SD 
Overweight 
Obese 
Morbidly obese 
-.23 
-.04 
.11 
2.11 
1.82 
1.96 
-.43 
.61 
.58 
1.60 
2.38 
2.60 
 
Table 5 
Two-Way ANOVA Results for BMI Change Scores  
Source df F Sig. 
Intervention 
BMI category 
Intervention x BMI category 
Error 
1 
2 
2 
453 
2.509 
4.727 
1.625 
.114 
.009 
.198 
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Table 6 
Independent t test Results for BMI Change Scores within BMI Categories 
BMI Category df t Sig. 
Overweight 
Obese 
Morbidly obese 
177 
129 
149 
.669 
-1.780 
-1.228 
.504 
.077 
.222 
 
 Cholesterol. The means and standard deviations for the cholesterol change scores 
across conditions and cholesterol levels are presented in Table 7. As shown in Table 7, 
the mean cholesterol change score for subjects with normal cholesterol levels (in the 
control and intervention groups) was positive. However, the mean cholesterol change 
score for subjects with elevated cholesterol levels (in both groups) was negative. 
The findings in Table 8 suggest that, first, cholesterol change scores did not vary 
significantly across conditions (F (1,646) = .000, p = .989); thus, participants in both the 
control and intervention groups had similar change scores. Second, cholesterol level 
change scores varied significantly across cholesterol levels (F (1,646) = 69.754, p = 
.000). In particular, the mean change score of participants classified as having a normal 
cholesterol level was significantly higher (M = 10.33) than the mean change score of 
participants classified as having an elevated cholesterol level (M = -12.51). Third, the 
findings indicate that the effect of the intervention on cholesterol level change scores did 
not vary across cholesterol levels (F (1,646) = .322, p = .571).  
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Table 7 
Means and Standard Deviations of Cholesterol Change Scores (N = 647)  
Cholesterol Category Control Intervention 
 Mean SD Mean SD 
Normal 
Elevated 
11.12 
-13.27 
31.54 
35.97 
9.53 
-11.75 
29.26 
32.83 
 
Table 8 
Two-Way ANOVA Results for Cholesterol Change Scores  
Source df F Sig. 
Intervention 
Cholesterol levels 
Intervention x cholesterol levels 
Error 
1 
1 
1 
646 
.000 
69.754 
.322 
.989 
.000 
.571 
 
 Systolic blood pressure. The means and standard deviations for the systolic 
change scores across conditions and blood pressure levels are displayed in Table 9. As 
shown in Table 9, the mean systolic blood pressure change scores were negative; only the 
mean change score of participants classified as having normal systolic blood pressure in 
the intervention group was positive.  
The findings in Table 10 reveal that systolic blood pressure change scores did not 
vary significantly across conditions (F (1,626) = .245, p = .621). Similarly, systolic blood 
pressure change scores did not vary significantly across blood pressure groups (F (1,626) 
= .047, p = .828). Further, the effect of the intervention on systolic blood pressure change 
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scores did not vary across blood pressure groups (F (1,626) = .428, p = .513).  
Table 9 
Means and Standard Deviations of Systolic BP Change Scores (N = 627) 
Blood Pressure Group Control Intervention 
 Mean SD Mean SD 
Normal 
Elevated 
-1.11 
-.40 
12.55 
21.25 
.77 
-.66 
12.43 
28.42 
 
Table 10 
Two-Way ANOVA Results for Systolic BP Change Scores  
Source df F Sig. 
Intervention 
Blood pressure group 
Intervention x blood pressure group 
Error 
1 
1 
1 
626 
.245 
.047 
.428 
.621 
.828 
.513 
 
 Diastolic blood pressure. The means and standard deviations for the diastolic 
change scores across conditions and blood pressure levels are presented in Table 11. As 
shown in Table 11, the mean diastolic blood pressure change scores were negative; only 
the mean change score of participants classified as having normal diastolic blood pressure 
in the intervention group was positive.  
The findings in Table 12 indicate that diastolic blood pressure change scores did 
not vary significantly across conditions (F (1,626) = .071, p = .790). Second, diastolic 
blood pressure change scores did not vary significantly across blood pressure groups (F 
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(1,626) = .134, p = .714). Lastly, the effect of the intervention on diastolic blood 
pressure change scores did not vary across blood pressure groups (F (1,626) = .636, p = 
.426).  
Table 11 
Means and Standard Deviations of Diastolic BP Change Scores (N = 627) 
Blood Pressure Category Control Intervention 
 Mean SD Mean SD 
Normal 
Elevated 
-.56 
-.06 
9.75 
11.44 
.05 
-1.29 
10.70 
16.51 
 
Table 12 
Two-Way ANOVA Results for Diastolic BP Change Scores  
Source df F Sig. 
Intervention 
Blood pressure group 
Intervention x blood pressure group 
Error 
1 
1 
1 
626 
.071 
.134 
.636 
.790 
.714 
.426 
 
Glucose. The means and standard deviations for the glucose change scores across 
conditions and glucose levels are displayed in Table 13. The mean glucose change scores 
for participants classified as having normal glucose levels was positive – thus indicating 
an increase in glucose levels across time. The mean glucose change scores for 
participants classified as having elevated glucose levels was negative – thus indicating a 
decrease in glucose levels across time.  
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The findings in Table 14 reveal that, first, glucose change scores varied 
significantly across conditions (F (1,560) = 4.287, p = .039). In particular, the mean 
change score of participants in the control group (M = -12.34) varied significantly from 
the mean change score of participants in the intervention group (M = -2.81); thus, glucose 
levels dropped more for participants in the control group. Second, glucose change scores 
varied significantly across glucose levels (F (1,560) = 20.867, p = .000). The mean 
change score of participants with normal glucose levels (M = 2.94) varied significantly 
from the mean change score of participants with elevated glucose levels (M = -18.08); 
thus, glucose levels dropped only for participants with elevated glucose levels. Third, the 
findings indicate that the effect of the intervention on glucose change scores varied across 
glucose levels (F (1,560) = 4.597, p = .032). As shown in Table 15, the intervention had a 
stronger (but not significant) effect on glucose change scores only for participants with 
elevated glucose levels (t (42) = -791, p = .433). Contrary to expectations, however, a 
larger change was observed in the control condition (M = -27.78; SD = 91.51) in 
comparison to the intervention condition (M = -8.38; SD = 71.07). 
 Table 13 
Means and Standard Deviations of Glucose Change Scores (N = 561) 
Glucose Levels Control Intervention 
 Mean SD Mean SD 
Normal  
Elevated 
3.11 
-27.78 
18.12 
91.51 
2.77 
-8.38 
21.50 
71.07 
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Table 14 
Two-Way ANOVA Results for Glucose Change Scores  
Source df F Sig. 
Intervention 
Glucose levels 
Intervention x glucose levels 
Error 
1 
1 
1 
560 
4.287 
20.867 
4.597 
.039 
.000 
.032 
 
Table 15 
Independent t test Results for Glucose Change Scores within Glucose Levels 
Glucose Levels df t Sig. 
Normal 
Elevated 
518 
42 
.189 
-.791 
.850 
.433 
 
The Relationship between Marital Status and BMI, Cholesterol Levels, Blood Pressure, 
and Glucose Levels 
The findings in Tables 16 and 17 reveal that BMI change scores did not vary 
significantly across marital status (t (605) = -.859, p = .391). Cholesterol change scores 
varied significantly across marital status (t (648) = 2.185, p = .029). The mean cholesterol 
change score for women who were not married was positive (M = 1.33; SD = 39.15), thus 
indicating that the mean cholesterol score for these women increased postscreening. The 
mean cholesterol change score for women who were married was negative (M = -4.78; 
SD = 31.20), thus indicating that the mean cholesterol score for these women decreased 
postscreening. Systolic blood pressure change scores did not vary significantly across 
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marital status (t (627) = .556, p = .578); diastolic blood pressure change scores did not 
vary significantly across marital status (t (627) = 1.295, p = .196); and glucose level 
change scores also did not vary significantly across marital status (t (562) = -.979, p = 
.328). 
Table 16 
Means and Standard Deviations of Change Scores across Marital Status Groups 
Change Score Not Married Married 
 
 Mean SD Mean SD 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
-.15 
1.33 
-.15 
.17 
.36 
2.11 
39.15 
14.99 
10.89 
22.60 
-.02 
-4.78 
-.83 
-.94 
2.78 
1.73 
31.20 
15.68 
10.58 
35.36 
 
Table 17 
Independent t test Results for Change Scores across Marital Status Groups 
Change Score df t Sig. 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
605 
648 
627 
627 
562 
-.859 
2.185 
.556 
1.295 
-.979 
.391 
.029 
.578 
.196 
.328 
 
 
  
 
75
The Relationship between Ethnicity and BMI, Cholesterol Levels, Blood Pressure, and 
Glucose Levels 
The findings in Tables 18 and 19 reveal that BMI change scores did not vary 
significantly across ethnic groups (t (606) = .334, p = .738). Cholesterol change scores 
also did not vary significantly across ethnic groups (t (649) = -1.063, p = .288). However, 
systolic blood pressure change scores varied significantly across ethnic groups (t (628) = 
2.148, p = .032). The mean systolic blood pressure change score for Non-White women 
was positive (M = 2.61; SD = 14.30), thus indicating that the mean systolic score for 
these women increased postscreening. The mean systolic blood pressure change score for 
White women was negative (M = -1.02; SD = 15.42), thus indicating that the mean 
systolic score for these women decreased postscreening. Diastolic blood pressure change 
scores; however, did not vary significantly across ethnic groups (t (628) = 1.453, p = 
.147). Lastly, glucose level change scores did not vary significantly across ethnic groups 
(t (562) = 1.211, p = .226). 
Table 18 
Means and Standard Deviations of Change Scores across Ethnic Groups 
Change Score NonWhite White 
 Mean SD Mean SD 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
-.03 
-5.05 
2.61 
1.09 
5.00 
1.97 
34.62 
14.30 
11.75 
43.66 
-.10 
-.93 
-1.02 
-.63 
.85 
1.93 
35.88 
15.42 
10.57 
25.83 
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Table 19 
Independent t test Results for Change Scores across Ethnic Groups 
Change Score df T Sig. 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
606 
649 
628 
628 
562 
.334 
-1.063 
2.148 
1.453 
1.211 
.738 
.288 
.032 
.147 
.226 
 
The Relationship between Level of Education and BMI, Cholesterol Levels, Blood 
Pressure, and Glucose Levels 
Although level of education initially consisted of six levels, due to small sample 
sizes in some categories, levels were collapsed to arrive at four levels. The first two 
levels (i.e., some high school and high school) were combined into a single category. The 
third and fourth levels (i.e., some technical school and some college) were grouped into a 
single category. 
As shown in Tables 20 and 21, BMI change scores, systolic blood pressure 
change scores, diastolic blood pressure change scores; cholesterol change scores, and 
glucose level change scores did not vary significantly across levels of education. 
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Table 20 
Means and Standard Deviations of Change Scores across Levels of Education 
Change Score Some High School or 
High School Graduate  
Some Technical 
School or College 
Technical School 
Graduate 
College 
Graduate 
 Mean SD Mean  SD Mean  SD Mean SD 
BMI 
 
Cholesterol 
level 
 
Systolic blood 
pressure 
 
Diastolic blood 
pressure 
 
Glucose level 
.03 
 
-4.63 
 
 
-.81 
 
 
-.48 
 
 
.39 
1.90 
 
38.20 
 
 
15.49 
 
 
11.13 
 
 
31.59 
-.26 
 
4.33 
 
 
-.94 
 
 
-.83 
 
 
4.14 
1.81 
 
30.44 
 
 
15.47 
 
 
10.27 
 
 
32.15 
-.32 
 
.55 
 
 
1.41 
 
 
.45 
 
 
2.02 
2.18 
 
33.95 
 
 
15.38 
 
 
9.90 
 
 
18.02 
.23 
 
1.37 
 
 
.46 
 
 
.59 
 
 
1.49 
2.11 
 
31.25 
 
 
13.93 
 
 
10.36 
 
 
11.62 
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Table 21 
ANOVA Results for Change Scores across Levels of Education 
Change Score MS df F Sig. 
BMI 
   Between groups 
   Within groups 
Cholesterol level 
   Between groups 
   Within groups 
Systolic blood pressure 
   Between groups 
   Within groups 
Diastolic blood pressure 
   Between groups 
   Within groups 
Glucose level 
   Between groups 
   Within groups 
 
4.514 
3.746 
 
3127.783 
1267.203 
 
121.655 
234.873 
 
43.059 
115.912 
 
447.659 
857.611 
 
3 
603 
 
3 
646 
 
3 
625 
 
3 
625 
 
3 
560 
 
1.205 
 
 
2.468 
 
 
.518 
 
 
.371 
 
 
.522 
 
.307 
 
 
.061 
 
 
.670 
 
 
.774 
 
 
.667 
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The Relationship between Age and BMI, Cholesterol Levels, Blood Pressure, and 
Glucose Levels 
Age was measured continuously but was transformed into a categorical variable. 
The whole sample was divided into three groups using the values at the 33rd and 66th 
percentiles. These percentiles were chosen so that the sample could be divided into three 
equal groups. Accordingly, women aged 38 years and younger were assigned to the first 
category; women between 39 and 48 were grouped into the second category; and women 
49 years and older were assigned into the third category. 
As can be gleaned from the findings in Tables 22 and 23, BMI change scores did 
not vary significantly across age groups (F (2,605) = .826, p = .438). Second, cholesterol 
change scores varied significantly across age groups (F (2,648) = 3.327, p = .037). The 
findings from a linear trend analysis reveal that cholesterol change scores increased 
across age groups (F (1,468) = 4.399, p = .036). Third, systolic blood pressure change 
scores did not vary significantly across age groups (F (2,627) = 1.445, p = .237). Fourth, 
diastolic blood pressure change scores also did not vary significantly across age groups 
(F (2,627) = 2.315, p = .100). Lastly, glucose level change scores did not vary 
significantly across age groups (F (2,561) = .048, p = .953). 
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Table 22 
Means and Standard Deviations of Change Scores across Age Groups 
Change Score 38 and Younger 39 to 48 49 and Older 
 Mean SD Mean  SD Mean  SD 
BMI 
 
Cholesterol level 
 
Systolic blood pressure 
 
Diastolic blood 
pressure 
 
Glucose level 
-.17 
 
2.35 
 
1.09 
 
1.01 
 
 
1.56 
2.13 
 
29.03 
 
13.21 
 
9.47 
 
 
26.98 
-.16 
 
-.40 
 
-1.20 
 
-1.02 
 
 
1.87 
1.98 
 
33.37 
 
15.79 
 
11.10 
 
 
32.80 
.05 
 
-6.23 
 
-1.11 
 
-.92 
 
. 
98 
1.68 
 
42.18 
 
16.42 
 
11.41 
 
 
27.36 
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Table 23 
ANOVA Results for Change Scores across Age Groups 
Change Score MS df F Sig. 
BMI 
   Between groups 
   Within groups 
Cholesterol level 
   Between groups 
   Within groups 
Systolic blood pressure 
   Between groups 
   Within groups 
Diastolic blood pressure 
   Between groups 
   Within groups 
Glucose level 
   Between groups 
   Within groups 
 
3.101 
3.753 
 
4207.498 
1264.805 
 
337.613 
233.639 
 
267.079 
115.393 
 
41.062 
858.329 
 
2 
605 
 
2 
648 
 
2 
627 
 
2 
627 
 
2 
561 
 
.826 
 
 
3.327 
 
 
1.445 
 
 
2.315 
 
 
.048 
 
.438 
 
 
.037 
 
 
.237 
 
 
.100 
 
 
.953 
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The Relationship between Smoking and BMI, Cholesterol Levels, Blood Pressure, and 
Glucose Levels 
The findings in Tables 24 and 25 indicate that, first, BMI change scores varied 
significantly across smoking groups (F (2,603) = 4.610, p = .010). Post-hoc Tukey test 
findings; however, did not yield any significant group comparisons. Further examination 
of the means in Table 24 reveals, however, that the mean BMI score of participants who 
smoked occasionally dropped the most across time (M = -.72) in comparison to 
participants who did not smoke at all (M = .05) and participants who smoked everyday 
(M = -.41). Second, cholesterol change scores did not vary significantly across smoking 
groups (F (2,645) = .718, p = .488). Third, systolic blood pressure change scores also did 
not vary significantly across smoking groups (F (2,626) = .103, p = .902). Fourth, 
diastolic blood pressure change scores did not vary significantly across smoking groups 
(F (2,626) = .201, p = .818). Finally, glucose level change scores changed marginally 
across smoking groups (F (2,558) = 2.892, p = .056). Examination of the means in Table 
24 suggests that the mean glucose score of participants who did not smoke at all 
increased the least across time (M = .40) in comparison to participants who smoked 
occasionally (M = 13.38) and participants who smoked everyday (M = 3.29). 
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Table 24 
Means and Standard Deviations of Change Scores across Smoking Groups 
Change Score Not at All Some Days Everyday 
 Mean SD Mean  SD Mean  SD 
BMI 
 
Cholesterol level 
 
Systolic blood 
pressure 
 
Diastolic blood 
pressure 
 
Glucose level 
.05 
 
-2.66 
 
-.63 
 
 
-.53 
 
 
.40 
1.95 
 
36.07 
 
15.50 
 
 
10.79 
 
 
27.16 
-.72 
 
.11 
 
36 
 
 
-.06 
 
 
13.38 
2.00 
 
30.06 
 
12.71 
 
 
9.53 
 
 
46.85 
-.41 
 
1.55 
 
-.15 
 
 
.12 
 
 
3.29 
1.76 
 
34.93 
 
15.28 
 
 
11.02 
 
 
30.81 
 
  
 
84
Table 25 
ANOVA Results for Change Scores across Smoking Groups 
Change Score MS df F Sig. 
BMI 
   Between groups 
   Within groups 
Cholesterol level 
   Between groups 
   Within groups 
Systolic blood pressure 
   Between groups 
   Within groups 
Diastolic blood pressure 
   Between groups 
   Within groups 
Glucose level 
   Between groups 
   Within groups 
 
16.938 
3.675 
 
909.982 
1267.521 
 
24.257 
234.838 
 
23.297 
116.111 
 
2459.772 
850.545 
 
2 
603 
 
2 
645 
 
2 
626 
 
2 
626 
 
2 
558 
 
4.610 
 
 
.718 
 
 
.103 
 
 
.201 
 
 
2.892 
 
.010 
 
 
.488 
 
 
.902 
 
 
.818 
 
 
.056 
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The Relationship between Income and BMI, Cholesterol Levels, Blood Pressure, and 
Glucose Levels 
As shown in Table 26, BMI change scores were not significantly correlated with 
income (r = -.03, p = .435). Cholesterol change scores were not significantly correlated 
with income (r = -.01, p = .893). Systolic blood pressure change scores were not 
significantly correlated with income (r = -.03, p = .414). Diastolic blood pressure change 
scores were not significantly correlated with income (r = .00, p = .988). Glucose level 
change scores were not significantly correlated with income (r = -.01, p = .763). 
Table 26 
Pearson Correlations between Change Scores and Income 
Change Score r Sig. 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
-.03 
-.01 
-.03 
.00 
-.01 
.435 
.893 
.414 
.988 
.763 
 
The Relationship between Number of Dependents and BMI, Cholesterol Levels, Blood 
Pressure, and Glucose Levels 
The findings in Table 27 reveal that, first, BMI change scores were significantly 
correlated with number of dependents (r = .10, p = .014). The more dependents women 
had, the lesser was their reduction in BMI. Cholesterol change scores were not 
significantly correlated with number of dependents (r = -.03, p = .529). Third, systolic 
blood pressure change scores were also not significantly correlated with number of 
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dependents (r = -.00, p = .952). Similarly, diastolic blood pressure change scores were 
not significantly correlated with number of dependents (r = -.01, p = .738). Lastly, 
glucose level change scores were not significantly correlated with number of dependents 
(r = .01, p = .780). 
Table 27 
Pearson Correlations between Change Scores and Number of Dependents 
Change Score r Sig. 
BMI 
Cholesterol level 
Systolic blood pressure 
Diastolic blood pressure 
Glucose level 
.10 
-.03 
-.00 
-.01 
.01 
.014 
.529 
.952 
.738 
.780 
 
Multivariate Results 
 The multivariate results are presented in this section.  
Overall Procedure 
Since level of education was a categorical variable with four groups, three dummy 
variables were created. The first category (i.e., those who had some high school or who 
graduated from high school) served as the anchor. Second, since age was a categorical 
variable with three groups, two dummy variables were created. The first category (i.e., 
the youngest group) served as the anchor. Finally, since smoking was a categorical 
variable with three groups, two dummy variables were created. The first category (i.e., 
the nonsmokers) served as the anchor. 
A forced-entry procedure was used. Specifically, all demographic variables and 
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preintervention screening weight were entered into the equation first. The intervention 
variable (with the control serving as the anchor) was entered into the equation last. 
Outliers on both the x- and y-space were detected using Cook’s D. Cases whose 
Cook’s D values were two standard deviations greater than the Cook’s D mean were 
deleted from the analysis. Since the regression results without the two outliers were 
similar to the regression results with the outliers, the latter regressions were retained. 
The assumptions of normality, linearity, and homoscedasticity were also verified. 
The normal probability plots indicated that the distributions were only slightly skewed. 
Plots of the standardized predicted values against the dependent variable revealed that 
linearity was not violated. Lastly, plots of the standardized predicted values against the 
studentized deleted residuals indicated that homoscedasticity was not violated. 
Change in BMI Scores 
The linear regression findings are shown in Table 28. The number of dependents 
women had significantly predicted change in BMI scores (B = .15; F (1,594) = 7.563, p = 
.006). The more dependents women had, the lesser was their reduction in BMI 
postscreening. Second, BMI prescreening scores also significantly predicted change in 
BMI scores (B = .09; F (1,594) = 4.737, p = .030). The higher the BMI prescreening 
score, the higher the BMI change score. 
After controlling for income, number of dependents, marital status, level of 
education, age, smoking status, and prescreening BMI, the WISEWOMAN intervention 
did not significantly predict change in BMI scores (B = .03; F (1,594) = .465, p = .495).  
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Table 28 
Multiple Linear Regression Results for BMI Change Scores (N = 607) 
Variable Beta F Sig. R2
Income -.03 .245 .621 .000 
Number of dependents .15 7.563 .006 .013 
Married vs. not married -.05 1.067 .302 .002 
Some technical/college vs. high school  -.06 1.746 .187 .003 
Technical school graduate vs. high school -.04 1.117 .291 .001 
College graduate vs. high school -.05 1.283 .258 .002 
39 to 48 vs. 38 and younger .05 .914 .339 .002 
49 and older vs. 38 and younger .10 3.814 .051 .006 
Occasional smoker vs. nonsmoker -.07 2.953 .086 .005 
Daily smoker vs. nonsmoker -.05 1.442 .230 .002 
Prescreening BMI .09 4.737 .030 .008 
Intervention .03 .465 .195 .000 
Overall model  2.230 .009 .043 
 
Change in Cholesterol Level Scores 
The linear regression findings in Table 29 show that level of education 
significantly predicted change in cholesterol scores (B = .11; F (1,609) = 7.088, p = .008). 
Women who took some high school classes or had graduated from high school had lower 
change in cholesterol scores than women who took some technical school or college 
classes. Age also significantly predicted change in cholesterol scores (B = -.12; F (1,609) 
= 5.421, p = .020). Women aged 38 years and younger had lower change in cholesterol 
scores than women aged 49 and older. 
After controlling for income, number of dependents, marital status, level of 
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education, age, smoking status, and prescreening BMI, the WISEWOMAN 
intervention did not significantly predict change in cholesterol scores (B = -.06; F (1,609) 
= 2.288, p = .131).   
Table 29 
Multiple Linear Regression Results for Change in Cholesterol Level Scores (N = 622) 
Variable Beta F Sig. R2
Income .03 .354 .552 .000 
Number of dependents -.05 .849 .357 .003 
Married vs. not married -.06 1.458 .228 .004 
Some technical/college vs. high school .11 7.088 .008 .008 
Technical school graduate vs. high school .04 .899 .343 .002 
College graduate vs. high school .05 1.384 .240 .003 
39 to 48 vs. 38 and younger -.05 .889 .346 .003 
49 and older vs. 38 and younger -.20 5.421 .020 .040 
Occasional smoker vs. nonsmoker .01 .092 .762 .000 
Daily smoker vs. nonsmoker .03 .364 .547 .000 
Prescreening BMI .04 .970 .325 .002 
Intervention .06 2.288 .131 .004 
Overall model  1.956 .026 .037 
 
Change in Systolic Blood Pressure Scores 
The findings in Table 30 reveal that none of the demographic variables 
significantly predicted change in systolic blood pressure scores. Further, after controlling 
for the effects of the demographic variables, the WISEWOMAN intervention did not 
significantly predict change in systolic blood pressure scores (B = .04; F (1,596) = 1.057, 
p = .304).   
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Table 30 
Multiple Linear Regression Results for Change in Systolic Blood Pressure Scores (N = 
609) 
 
Variable Beta F Sig. R2
Income 
Number of dependents 
Married vs. not married 
Some technical/college vs. high school 
Technical school graduate vs. high school 
College graduate vs. high school 
39 to 48 vs. 38 and younger 
49 and older vs. 38 and younger 
Occasional smoker vs. nonsmoker 
Daily smoker vs. nonsmoker 
Prescreening BMI 
Intervention 
Overall model 
-.03 
.01 
-.00 
-.01 
.05 
.03 
-.08 
-.07 
-.01 
.02 
-.04 
.04 
.476 
.017 
.003 
.031 
1.393 
.456 
2.563 
1.743 
.054 
.145 
1.045 
1.057 
.675 
.491 
.897 
.955 
.860 
.238 
.500 
.110 
.187 
.816 
.703 
.307 
.304 
.776 
.000 
.000 
.000 
.000 
.003 
.000 
.006 
.005 
.000 
.000 
.002 
.002 
.013 
 
Change in Diastolic Blood Pressure Scores 
As shown in Table 31, none of the demographic variables significantly predicted 
change in diastolic blood pressure scores. Similarly, after controlling for the effects of the 
demographic variables, the WISEWOMAN intervention did not significantly predict 
change in diastolic blood pressure scores (B = .02; F (1,609) = .193, p = .661).   
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Table 31 
Multiple Linear Regression Results for Change in Diastolic Blood Pressure Scores (N = 
609) 
 
Variable Beta F Sig. R2
Income 
Number of dependents 
Married vs. not married 
Some technical/college vs. high school 
Technical school graduate vs. high school 
College graduate vs. high school 
39 to 48 vs. 38 and younger 
49 and older vs. 38 and younger 
Occasional smoker vs. nonsmoker 
Daily smoker vs. nonsmoker 
Prescreening BMI 
Intervention 
Overall model 
.03 
-.03 
-.04 
-.02 
.03 
.03 
-.09 
-.09 
.01 
.02 
-.03 
.02 
.282 
.218 
.820 
.270 
.475 
.373 
3.677 
3.090 
.013 
.198 
.527 
.193 
.668 
.595 
.640 
.365 
.603 
.491 
.542 
.056 
.079 
.908 
.656 
.468 
.661 
.783 
.000 
.000 
.002 
.000 
.000 
.000 
.008 
.008 
.000 
.000 
.000 
.000 
.013 
 
Change in Glucose Level Scores 
The linear regression findings in Table 32 indicate that smoking significantly 
predicted change in glucose level scores (B = .12; F (1,531) = 6.909, p = .009). Women 
who occasionally smoked cigarettes had higher glucose change scores than women who 
did not smoke cigarettes. After controlling for the effects of the demographic variables, 
the WISEWOMAN intervention did not significantly predict change in glucose level 
scores (B = -.00; F (1,531) = .006, p = .941).    
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Table 32 
Multiple Linear Regression Results for Change in Glucose Level Scores (N = 544) 
Variable Beta F Sig. R2
Income 
Number of dependents 
Married vs. not married 
Some technical/college vs. high school 
Technical school graduate vs. high 
school 
College graduate vs. high school 
39 to 48 vs. 38 and younger 
49 and older vs. 38 and younger 
Occasional smoker vs. nonsmoker 
Daily smoker vs. nonsmoker 
Prescreening BMI 
Intervention 
Overall model 
-.04 
.00 
.07 
.07 
.01 
.02 
-.00 
-.00 
.12 
.07 
.08 
-.00 
.574 
.005 
2.022 
2.153 
.016 
.304 
.007 
.001 
6.909 
2.244 
3.078 
.007 
1.125 
.449 
.946 
.156 
.143 
.898 
.582 
.933 
.969 
.009 
.135 
.080 
.934 
.337 
.000 
.000 
.005 
.005 
.000 
.000 
.000 
.000 
.014 
.004 
.006 
.000 
.025 
 
Summary 
 The results of this analysis did not support hypotheses 1 through 4. The 
WISEWOMAN screening session identifies cases of abnormal blood pressure, blood 
glucose, total cholesterol, and BMI that otherwise would go undiagnosed; however, the 
overall effectiveness of the LSI on blood pressure, blood glucose, total cholesterol, and 
BMI is not supported by the analysis.   
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The Relationship between Conditions and Outcomes 
BMI  
There was no significant difference in BMI by condition (intervention vs. 
control). The intervention did not have a significant effect on BMI change; however, 
there were marginal (but not significant) differences in BMI change scores across the 
three BMI categories. 
Mean BMI across Time 
(p = .114)
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Figure 4. Mean BMI across time. 
Total Cholesterol 
There was no significant difference in cholesterol by condition (intervention vs. 
control); however, there were differences in cholesterol change scores across the two 
cholesterol change categories.  
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Mean Cholesterol Level across Time
(p = .989)
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Figure 5. Mean cholesterol level across time. 
 
Systolic Blood Pressure  
There was no significant difference in systolic blood pressure change by condition 
(intervention vs. control). There were no differences in systolic blood pressure change 
scores across the two systolic categories (normal and elevated).  
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Change in Systolic Blood Pressure across Time
(p = .621)
120
121
122
123
124
Baseline Outcome
Time
M
ea
n 
Sy
st
ol
ic
 B
lo
od
 P
re
ss
ur
e
Control
Intervention
 
Figure 6. Change in systolic blood pressure across time. 
Diastolic Blood Pressure 
 There was no significant difference in diastolic blood pressure change by 
condition (intervention vs. control). There were no differences in diastolic blood pressure 
change scores across the two diastolic categories (normal and elevated). In addition, none 
of the diastolic blood pressure groups changed significantly from pre to post. 
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Change in Diastolic Blood Pressure across Time
(p = .790)
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Figure 7. Change in diastolic blood pressure across time. 
Glucose  
Glucose change scores varied significantly across conditions (treatment vs. 
control) and across glucose levels (normal vs. elevated). The intervention had a stronger 
effect, although not statistically significant, on glucose change scores only for 
participants with elevated glucose levels. Over time there was a bigger change in the 
control condition (M = -27.78) than in the intervention condition (M = -8.38). 
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Change in Glucose Level across Time 
(p = .039)
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Figure 8. Change in glucose level across time. 
 The following chapter will review the study and present conclusions about the 
outcomes. Chapter 5 will also discuss the social change implications of these findings, 
the limitations of this study, and future recommendations for continued research in this 
area.      
  
CHAPTER 5: 
DISCUSSION 
Introduction and Summary of the Multivariate Results 
In regard to BMI, significant variables emerged as predictors of change in BMI. 
The number of dependents women had significantly predicted change in BMI in that the 
more dependents women had; the less was their reduction in BMI. The initial screening 
BMI significantly predicted change in that the higher the woman’s BMI was at the initial 
screening, the greater the decrease in BMI at rescreening. When income, number of 
dependents, marital status, education level, age, smoking status, and prescreening BMI 
were included in the regression model, the WISEWOMAN intervention did not 
significantly predict change in BMI scores, suggesting no differences between the 
comparison versus intervention group.  
The linear regression indicated that the level of education significantly predicted 
change in total cholesterol scores. Women who took some high school classes or had 
graduated from high school had less change in cholesterol than women who took some 
technical school or college classes. Age also significantly predicted change in cholesterol 
scores, in that women aged 38 years and younger had lower change in cholesterol scores 
than women aged 49 and older. When income, number of dependents, marital status, 
level of education, age, smoking status, and prescreening BMI were included in the 
regression model, the WISEWOMAN intervention did not significantly predict change in 
cholesterol scores. 
The linear regression revealed that smoking significantly predicted change in 
glucose level scores. Women who occasionally smoked cigarettes had higher change 
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scores than women who did not smoke cigarettes; however, the WISEWOMAN 
intervention did not significantly predict change in glucose level scores.   
The demographic variables did not significantly predict change in either systolic 
or diastolic blood pressure scores.  
Comparison to Previously Published Studies of Similar Interventions 
The results of this analysis contribute to the knowledge of heart disease risk factor 
prevalence among women enrolled in the South Dakota WISEWOMAN program. It was  
hypothesized that SD WISEWOMAN participants attending the screening sessions, as 
well as the intervention sessions, would have lower levels of blood pressure, blood 
glucose, total cholesterol, and obesity at clinical rescreening 10 to14 months later. 
Contrary to expectations, the data revealed that differences in blood pressure, blood 
glucose, total cholesterol, and BMI were not observed. One possible explanation for this 
finding is that the WISEWOMAN screening session alone initiated a woman’s 
motivation to change. Other possible explanations for these findings include differences 
in study methods, flaws in the transtheoretical model, or lack of perfect fidelity to the 
transtheoretical model. The methods included in this study differ from other 
WISEWOMAN studies in that there was no assignment to groups (screenings sessions 
only or screening sessions with interventions). The women self-selected without 
randomization to groups, therefore it is difficult to discern the extent to which 
intervention attendance truly impacted the outcomes. Recently there has been an increase 
in research denouncing the transtheoretical model because of analytic, conceptual, and 
methodological issues. The transtheoretical model of behavior change is a relatively new 
behavior theory that does not have the longevity of research to support it, in comparison 
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to other theoretical constructs (Bandura, 1997). The WISEWOMAN program is 
completely based on the provider site staff and the interventionists. Although numerous 
training sessions are provided, as well as a WISEWOMAN policy and procedure manual, 
clinicians and interventionists’ adherence to the theoretical foundation of the 
WISEWOMAN program is questionable. The WISEWOMAN program administrators 
are not able to monitor program fidelity (Hutchison, Breckon, & Johnston, 2008).  
Between January 2001 and December 2005, 653 women were screened and 
rescreened by the program. Additionally, implementation of programs, such as 
WISEWOMAN, is becoming more important as the female population in SD grows older 
and the burden of chronic disease increases. This research illustrates the potential value 
of additional screening to identify women with abnormal blood glucose, blood pressure, 
total cholesterol, and BMI who would not have otherwise been diagnosed. These results 
confirm that the WISEWOMAN program presents a unique opportunity to reach 
financially vulnerable populations at high risk for chronic and communicable diseases 
(Glaser & Greifinger, 1993).  
The women in this study self-selected without randomization to groups, therefore 
it is difficult to discern the extent to which the intervention attendance truly impacted the 
outcomes. Mercer and her colleagues (2007) concluded that utilizing a pre-post in a 
quasi-experimental study is useful in investigating the feasibility of an intervention and 
are better than a randomized post test. Vandenbroucke et al. (2007) suggested that the 
overall generalizability or external validity of a study is significant only with regard to 
specific circumstances. Diversity in population, severity of disease, co-occurring 
disorders, and exposure all impact external validity. Vandenbroucke et al. also 
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acknowledged that using data collected in the past poses as a threat to external 
validity in that it is questionable how applicable the results are to the current population. 
In six of the eight WISEWOMAN studies, women were randomly assigned to a control 
versus intervention group. Furthermore, the rigor of randomized trials is unlikely to be 
replicated in real-world situations, which significantly weakens their external validity. 
This point is supported by the less impressive findings that were produced from this 
natural experiment, which is more realistic than a randomized trial would be. In short, the 
design of this study is weaker that most of the others in regard to internal validity but 
stronger in regard to external validity. 
The sample size for this study consisted of 653 women, which is mid-range 
compared to other WISEWOMAN sample sizes. The WISEWOMAN workgroup (1999) 
had the largest sample consisting of 4842 women from Massachusetts, Arizona, and 
North Carolina. The smallest sample consisted of 217 women from the Arizona 
WISEWOMAN project (Staten et al., 2004). This research project categorized the women 
into groups based on biomarker results. Women were classified as normal, meaning there 
were no elevated levels at time of initial screening or elevated, meaning that they had a 
minimum of one elevated biomarker level. To date, there are no other WISEWOMAN 
studies that have used this classification in their analysis.   
This dissertation evaluated a lifestyle intervention that primarily targeted nutrition 
and physical activity to reduce risk of cardiovascular disease, while the other studies 
compared and contrasted the minimal versus the enhanced interventions. The enhanced 
intervention includes the former, plus one-on-one nutritional and physical activity 
assessments and counseling, individual and group education, and behavioral intervention 
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activities. Data analysis was similar to other WISEWOMAN studies in that use of 
descriptive statistics and regression analysis was a common approach. The dependent 
variables (change in blood glucose levels, change in BMI, change in total cholesterol 
levels, and change in blood pressure) were constant across the studies, as the 
WISEWOMAN program has a standard Minimal Data Element (MDE).  
The WISEWOMAN program addresses racial/ethnic disparities in cardiovascular 
disease. NonWhite women in the South Dakota WISEWOMAN program exhibit more 
health disparities than White women. Systolic blood pressure change scores varied 
significantly across ethnic groups. NonWhite women experienced less change in systolic 
blood pressure, as compared to White women. Finkelstein et al. (2004) concluded that 
BMI, blood pressure, total cholesterol, blood glucose, as well as smoking prevalence was 
greater among minority populations than among the White population.   
A woman’s age is suggestive of the overall change a woman will experience from 
screening to rescreening. This research suggests that total cholesterol change scores 
varied significantly across age groups. South Dakota women aged 49 years and older 
experienced more cholesterol change than women 38 years and younger. This is in line 
with the work of Feresu et al. (2008) who found that among Nebraska WISEWOMAN 
participants, age was the most significant factor in determining cardiovascular risk.  
Overall, the results of this dissertation did not confirm the findings of other 
similar WISEWOMAN studies. Of the eight total WISEWOMAN studies that focused on 
change in biomarkers, six of them demonstrated positive results in that the interventions 
were effective. The methods used in previous WISEWOMAN studies differ greatly based 
on location, sample size, demographics, random assignment, intervention intensity, 
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longevity and funding level, as well as the overall analysis. The results of this 
dissertation do not support the research hypotheses and therefore are not supportive of the 
current WISEWOMAN intervention component in promoting change among 
underinsured and uninsured women residing in South Dakota.  
Limitations 
The results of this study are limited in that regional and cultural differences, as 
well as participation in the South Dakota WISEWOMAN program may influence 
perceived barriers to intervention attendance and health behavior change. Women in the 
more remote areas of the state are less likely to participate in the face to face intervention 
sessions than those women residing in more urban areas (South Dakota Department of 
Health, 2009). In addition, the sample was limited to participants eligible to participate in 
the South Dakota WISEWOMAN cohort and subjects were not randomly assigned to 
group (comparison vs. intervention). The implementation of the WISEWOMAN program 
in this state did not take into account a woman’s readiness to change and differing levels 
of risk. Participants were assigned to an LSI according to their bio-marker levels, not in 
relation to a woman’s risk, perceived risk, and readiness to change. Many women do not 
attend an LSI because they do not perceive their risk to be elevated.  
 Participants were advised to fast before blood tests, but no means of verification 
was available.  Consequently, some measurement error may have been introduced into  
laboratory tests, thus increasing random fluctuation.  Any such error would have been 
randomly distributed between groups and should not have introduced systematic bias. 
The results of this dissertation study did not take into account confounding 
variables that were not measured or analyzed. The reality that attendance of intervention 
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sessions is crowded out by other obligations highlights the difficulty of attracting 
women to attend intervention sessions. In 2001, Krummel and colleagues recommended 
that public health programs target broad environmental influences on health. Rural 
communities are challenged in providing fresh fruits and vegetables in the local grocery 
stores. These same communities also lack environments where women can walk safely in 
extreme weather conditions. Nearly two-thirds of SD WISEWOMAN participants are 
working (South Dakota Department of Labor, 2007), therefore making childcare an issue. 
Other variables that were not taken into account include other co-occurring health issues, 
motivation, cultural beliefs/norms, cost (both monetary and time), transportation, 
weather, and support from family and friends.  
Methodological issues in the sample for this research limit the external validity of 
this study. Since clients were not randomly assigned to groups, unmeasured variables 
could confound the results. Another limitation of the study is the absence of medication 
histories for each participant. The South Dakota Department of Health or MaxTrac chose 
not to include medications in the MDE (minimal data elements) that it collects because 
all participants in need of medications were referred to the Department of Social Services 
RX Access program. 
American Indian data are lacking in this dissertation study because of a simple 
billing issue. Indian Health Service (IHS) does not submit bills to the South Dakota 
WISEWOMAN program for screening. If the program does not pay the bill, then the 
woman can not be enrolled in the WISEWOMAN program. This is a relatively 
straightforward problem to fix; however, it has been ongoing since the program began. 
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Recommendations for Future Research 
More research is needed in order to confirm or dispute the findings reported here.  
A randomized experiment should be undertaken to test the assumption that selection bias 
did not affect the conclusions of this observational study.  Specifically, the possibility 
that women who attended the lifestyle sessions were clinically, socially or 
psychologically different from those who only participated in screening should be 
investigated. 
Recommendations for Action and Implications for Social Change  
The results of this dissertation indicated that programs intending to promote 
improved lifestyles among disadvantaged women should rely heavily on screenings to 
identify diseases that otherwise would go undiagnosed. The data presented here do not 
support continued reliance on the full WISEWOMAN program package, since the 
lifestyle change sessions appear to not offer an incremental improvement in biomarkers. 
Dissemination Plan 
Dissertation results will be disseminated in a timely, responsible, and respectful 
manner to the South Dakota WISEWOMAN program, the South Dakota Department of 
Health, CDC, State of South Dakota legislators, as well as other stakeholders and 
community coalitions that could be potentially impacted by the research results and 
conclusions. The results will be shared via state and national poster/oral presentations, 
peer reviewed journal articles, and special executive summaries.  
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